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要約 
TRIM27（別名 RFP）は TRIM ファミリーに属し、RING ドメインを持つことから、
ユビキチン E3リガーゼと考えられてきた。いくつかの研究から、異なるユビキチン
E3リガーゼが様々な制御因子をユビキチン化することにより、アポトーシス、TNF-、
自然免疫シグナリングに重要な役割を果たすことが示されている。しかし、TRIM27
のこれらのシグナリングにおける役割は不明である。また SNPs と疾患とのゲノム
ワイドリンケージに関する研究から、ヒト TRIM27 遺伝子は、いくつかの自己免疫
疾患に関与することが示唆されているが、実験的な証拠はない。本研究では、TRIM27
のアポトーシス、TNF-シグナリングにおける役割を明らかにし、自己免疫疾患と
の関連を明らかにした。 
  マウスにTNF-α/GalN を投与すると、肝障害が誘導される。Trim27-/- 変異マウ
スでは、野生型マウスに比べ、肝障害の程度が明らかに弱かった。さらにマウス線
維芽細胞では、TNF-α /CHX により誘導されるアポトーシスの程度が、野生型細胞
に比べ低いことが示された。TNF- シグナリングでは、complex I 依存性のsurvival 
シグナリングとcomplex II 依存性のアポトーシスシグナリングの２つが存在する。
前者の下流のNFκB 標的遺伝子（cFLIP, cIAP2, A20, ICAM）の発現は、Trim27-/- 細胞
と野生型細胞で差がなかった。一方、complex IIの形成を免疫共沈法で調べると、
Trim27
-/-
 細胞ではcomplex II形成が低下していた。このメカニズムをさらに詳細に解
析した所、１）TRIM27は脱ユビキチン化酵素USP7をユビキチン化し、その活性を
活性化すること、２）活性化されたUSP7はRIP1からユビキチンを除去することが示
された。これまで他のグループにより、RIP1からの脱ユビキチンは、complex II 形
成に必須であることが示されている。以上の結果から、TRIM27はUSP7を介して、
RIP1の脱ユビキチン化を促進することにより、TNF- によるアポトーシスを正に制
御することが示された。 
  一方、TRIM27 と自己免疫疾患との関連を明らかにするため、streptozotocin (STZ)
により誘導されるマウス糖尿病モデルを用いた。Trim27-/- マウスは野生型マウスに
比べ、STZ誘導性の糖尿病を発症し易いことが示された。Trim27-/- 細胞マウスでは、
β 細胞の減少、活性化 caspase-3 シグナルと T細胞浸潤の亢進が認められた。以上の
結果は、TRIM27 遺伝子の変異が、I型糖尿病などのある種の自己免疫疾患の発症に
関与することを示唆するものである。 
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Abstract                              
Purpose: TRIM27 (also known as the Ret Finger Protein, RFP) is one of the TRIM 
family proteins and due to the presence of RING domain in its structure, TRIM27 has 
been regarded as the ubiquitin E3 ligase enzyme for a long time. Several studies suggest 
that different E3 ligase enzymes play a key role in the regulation of apoptosis, TNF-α or 
innate immune signaling pathway by ubiquitinating various regulatory molecules. 
However, the role of TRIM27 in those pathways is still not clear. Although, previous 
study suggests that over-expression of TRIM27 in human embryonic kidney cell could 
induce the apoptosis but detailed mechanism is still unknown. Moreover, more than 
30 genome-wide association studies, in several autoimmune diseases, identified 
hundreds of common variants, which suggested a linkage between TRIM27 mutations 
and various autoimmune diseases but there is no experimental evidence in support of 
this hypothesis. In this context, the aim of our study is to unravel the mechanism of 
TRIM27 in apoptosis and TNF-α signaling pathway and find out it’s connection with 
autoimmune diseases by using murine model system. 
 
Materials and Methods: Trim27
-/-
 mice were generated by homologous recombination 
in TT2 ES cells. To understand the physiological role of TRIM27 in TNF-α induced 
apoptosis TNF-α/GalN-induced hepatitis mouse model were utilized. Mouse hepatitis 
were characterized by measuring serum ALT, AST, bioassay of caspase-3 and 8 in liver 
homogenate and histo-pathological analysis of liver tissue sections by TUNEL analysis, 
H&E staining and immunohistochemistry using cleaved caspase-3. Mouse embryonic 
fibroblasts (MEFs) were isolated from embryos at 14.5 days postcoitus and 
spontaneously immortalized MEFs were isolated. To examine cell viability of MEF, 
cells (1x10
4
) were seeded into 96 well plates. At 24 h after incubation, cells were treated 
with various combination of recombinant mouse TNFα, cyclohexamide, anti-FAS 
antibody, TRAIL with enhancer antibody, etoposide or USP7 inhibitor HBX 41,108 for 
indicated time point and cell viability was assessed colorimetrically using the cell 
counting kit-8. Flow cytometry was used to check the expression of TNF-α receptor in 
MEF. NFκB acticity was assessed by elotrophoretic mobility shift assay. NFκB target 
gene expression was analyzed by Real-time RT-PCR. The subcellular localization of 
TRIM27, USP7 or RIP1 were performed immunohistochemically or biochemically by 
Nycodenz gradient fractionation. Protein levels of the apoptosis-regulating factors were 
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determined by Western blotting. Ubiquitination of endogenous and exogenously 
expressed proteins (RIP1, TRIM27 or USP7) were checked by in vivo ubiquitination 
assay in 293T and MEF cell line. Protein-protein interactions of TRIM27, USP7 and 
RIP1 or TNF-α induced complex II formation were checked by co-immunoprecipitation 
methods. shRNA and siRNA specific for USP7 were used for knockdown of USP7 in 
293T or MEF cell line. Multiple low dose streptozotocin (STZ) induced diabetes model 
were used to assess the role of TRIM27 in autoimmune type I diabetes. Diabetes were 
characterized by measuring the blood glucose (by glucometer), insulin (by ELISA) and 
histopathological analysis of paraffin section of mouse pancreas by HE staining, anti 
CD3, anti-cleaved caspase-3 or anti-insulin immunohistochemistry. 
 
Results and Discussion: As TRIM27 is an ubiquitin E3 ligase, and ubiquitination plays 
a role in the regulation of TNF-α signaling, we examined TNF-α signaling in Trim27-/- 
mice. We used a D-galactosamine (GalN) sensitized mouse model of liver injury in 
which TNF-α induces hepatocyte apoptosis in the presence of GalN. WT mice treated 
with TNF-α and GalN died within 10 h, whereas 60% of Trim27-/- mice treated under 
the same conditions survived and lived even 24 h after injection. TNF-α-induced 
apoptosis was further examined in primary MEFs. The viability of WT MEFs was 
significantly reduced when treated with TNF-α together with the protein synthesis 
inhibitor cyclohexamide (CHX). In contrast, TNF-α /CHX treatment only slightly 
reduced the cell viability of primary Trim27
-/-
. 
  
To determine whether TRIM27 plays a role in TNF-α induced survival signaling, NFκB 
activity and NF-κB target gene expression of typical survival-related genes (including 
cFLIP, cIAP2, A20, and ICAM ) were assessed in the presence or absence of TNF-α . 
The result showed that NFκB activity and the expression levels of these genes were 
similar between WT and Trim27
-/- MEF indicating that TRIM27 does not affect TNF-α 
survival signaling. To investigate the role of TRIM27 in the complex II-dependent 
apoptosis pathway, the complex II formation was compared between WT and Trim27
-/-
 
MEFs. The levels of RIP1 and caspase-8 co-immunoprecipitated with FADD were 
found lower in Trim27
-/-
 cells than in WT cells after TNF-α/CHX treatment. These 
results suggest that TRIM27 is involved in the complex II-dependent apoptosis pathway, 
but not in the complex I-dependent survival signaling pathway.  
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As TRIM27 has been reported to have E3 ligase activity, we therefore hypothesized that 
the effect of TRIM27 on TNF-α-induced apoptosis may be mediated by ubiquitination 
of a regulatory factor. Of the several candidates examined, TRIM27 only affected the 
ubiquitination status of RIP1. However, contrary to its expected function as an Ub E3 
ligase, TRIM27 deubiquitinated RIP1. In the co-immunoprecipitation assay, RIP1 was 
co-precipitated with TRIM27, suggesting the interaction between TRIM27 and RIP1. 
To understand the mechanism underlying the deubiquitination of RIP1 by TRIM27, 
TRIM27 interacting proteins were identified by purifying the complex formed. 
Through mass spectrometric analysis we determined the purified complex contained a 
120-kD band identified as USP7 a ubiquitin-specific protease. USP7 colocalized with 
TRIM27 in the cytoplasm and in the nucleus of HepG2 cells and MEFs suggesting that 
these proteins interact. Furthermore, USP7 co-immunoprecipitated with TRIM27 cells 
transfected with the TRIM27 expression vector. To examine whether USP7 is needed 
for the TRIM27-induced deubiquitination of RIP1, we generated Usp7-knockdown 
293T cell lines. When RIP1 was co-expressed with increasing amounts of TRIM27 in 
this cell line, RIP1 deubiquitination was not observed indicating that USP7 is required 
for the TRIM27-induced deubiquitination of RIP1. These results suggest that the 
TRIM27-USP7 complex binds to RIP1, resulting in its deubiquitination. To examine the 
role of TRIM27 in the TRIM27/USP7 complex-induced deubiquitination of RIP1, we 
investigated whether TRIM27 ubiquitinates USP7. Ubiquitination assays in 293T cells 
showed that TRIM27 mediates the addition of poly-Ub chains to USP7. Expression 
back of siRNA-resistant WT USP7 mRNA in Usp7-knockdown 293T cells recovered 
the TRIM27-induced RIP1 deubiquitination, whereas overexpression of 
siRNA-resistant ubiquitin site mutant USP7-K869R mRNA did not. These results 
indicate that the ubiquitination of USP7 by TRIM27 is required for the 
TRIM27-induced deubiquitination of RIP1.  
 
To confirm that USP7 plays a role in TNF-α-induced apoptosis, Usp7 mRNA was 
down-regulated in immortalized MEF by using mouse siRNA. Down-regulation of 
USP7 made the cells resistant to TNF-α/CHX-induced apoptosis compared to control 
cells. We next examined the ubiquitination of endogenous RIP1 in response to 
TNF-α/CHX treatment using WT, Trim27-/-, and Usp7 knockdown MEF cell lines. The 
level of ubiquitinated RIP1 in Trim27
-/-
 cells and Usp7 knockdown cells was higher than 
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in WT and control cells which further support that the TRIM27/USP7 complex plays a 
role in TNF-α-induced apoptosis by mediating RIP1 deubiquitination.  
 
Multiple studies have suggested a link between TNF-α pathway and various diseases, 
such as diabetes. Here, we report that Trim27-deficient mice were susceptible to 
multiple low dose streptozotocin (STZ)-induced diabetes, a mouse model of diabetes. 
Infiltration of T cells and cleaved caspase-3 signals were enhanced, and β-cell mass was 
decreased in Trim27-deficient islets compared to wild-type islets.  Our findings were 
also consistent with the results of recent genome-wide association studies linking 
autoimmune diseases and genetic polymorphisms, which showed an association 
between human TRIM27 genes and Type 1 diabetes. Although in this study we couldn’t 
show any direct evidence in support of the mechanism of crosstalk between defective 
apoptosis and development of diabetes, however, as the Trim27
-/-
 mice showed 
increased infiltration of lymphocyte in the pancreas in response to STZ, we speculate 
that peripheral lymphocyte homeostasis and self tolerance mechanism to minimize the 
accumulation of autoreactive lymphocytes might be defective in Trim27
-/-
 mice due to 
abrogated TNF-α-induced apoptosis. 
 
Conclusion: Here, we show that TRIM27, a tripartite motif (TRIM) protein containing 
RING finger, B-box, and coiled-coil domains, positively regulates TNF-α-induced 
apoptosis. Trim27-deficient mice are resistant to TNF-α/D-galactosamine-induced 
hepatocyte apoptosis. Trim27-deficient mouse embryonic fibroblasts (MEFs) are also 
resistant to TNF-α/cycloheximide-induced apoptosis. TRIM27 forms a complex with 
and ubiquitinates the ubiquitin-specific protease USP7, which deubiquitinates 
receptor-interacting protein 1 (RIP1), resulting in the positive regulation of 
TNF-α-induced apoptosis. Trim27-deficient mice were susceptible to streptozotocin 
(STZ)-induced diabetes, a mouse model of Type I diabetes. Our findings indicate that 
the ubiquitination-deubiquitination cascade mediated by the TRIM27-USP7 complex 
plays an important role in TNF-α-induced apoptosis. 
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Chapter 1 
1. Introduction and Review of Literature                                       
1.1 Apoptosis 
Apoptosis is a tightly regulated cellular suicide process essential for normal 
development and tissue homeostasis of all multicellular organisms [1]. In addition, 
apoptosis is also used as a defense strategy against persistent viral infection, 
autoimmunity and the emergence of cancer [2]. Dysregulation of this exact program not 
only interferes with normal physiology but also often leads to pathology and disease. In 
particular, every immunological and oncological disease can be traced to defects in 
apoptosis, thus generating a great interest and urgency in the understanding of 
mechanisms that underlie apoptosis signaling. 
The name apoptosis originates from a Greek term meaning “the falling off of the 
leaves” [3]. The typical morphological features of apoptosis include- nuclear 
fragmentation, blebbing of the plasma membrane, cytoplasmatic shrinkage resulting in 
the formation of apoptotic bodies. Additionally, typical biochemical features of 
apoptosis are internucleosomal DNA fragmentation and externalization of molecules, 
such as phosphatidylserine, that are involved in the clearance of dead cells, allowing to 
recognize these cells and remove them [4-6]. 
The molecular apoptotic machinery in mammals is very complex and involves many 
redundant molecules (Figure 1.1). Diverse stimuli can trigger apoptosis, generally by 
affecting particular receptors (death receptors) or in a receptor-independent way by 
mitochondria or endoplasmic reticulum alteration [7].  
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The apoptotic cell death programme culminates in the activation of caspases, a family 
of highly specific cysteine proteases essential for the destruction of the cell [8]. 
Usually, caspases are expressed as inactive zymogens that are activated in cascades of 
auto- and trans-stimulation. Once activated, initiator caspases cleave and activate 
downstream effector caspases, thereby amplifying the proteolytic activity. Two major 
caspase-activating pathways have been identified [9]. Developmental cues or cellular 
stress such as DNA damage or Ca2+ overload induce the ‘intrinsic’ pathway, whereas 
immune-mediated death-receptor stimulation activates the ‘extrinsic’ pathway. In the 
intrinsic pathway, both the permeabilization of the mitochondrial membrane and the 
release of pro-apoptotic molecules from the intermembrane space into the cytoplasm are 
crucial for activation of the initiator caspase caspase-9 [10]. Release of cytochrome c 
causes the formation of the apoptosome, a multicomponent adaptor complex that serves 
as a catalyst for caspase-9 oligomerization and activation [11].   
By contrast, the extrinsic pathway is triggered through binding of an apoptotic signal 
(Fas, tumour necrosis factor - TNF) to a TNFR (TNF receptor) family protein 
(Fas/CD95/Apo-1, TRAIL, DR4, DR5 etc.) that initiate the assembly of 
caspase-8-activating platforms at the plasma membrane (Figure 1.1) [12]. Though the 
initiation and the spectrum of early caspase activation differ between intrinsic and 
extrinsic pathways, both pathways converge at the activation of caspase-4. In particular, 
caspase-3 functions as the most prevalent effector caspase. For example, DNA 
fragmentation mediated by caspase-activated DNAse [CAD/DNA fragmentation 
factor-40 (DFF-40)] requires the caspase-3-mediated cleavage of its inhibitor of caspase 
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activated DNase (ICAD)/DFF-45 for nuclear translocation and activity [13].  
 
[Photograph source: Reference no. 12] 
Figure 1.1 Mechanism of Apoptosis. Cell death in mammals is triggered by either extrinsic or 
intrinsic apoptotic molecular pathway. The extrinsic (receptor mediated) pathway includes 
binding of death ligands (FasL) to their receptors and subsequent requirement of adaptor 
molecules (FADD), thus forming a death inducing complex (DISC) within caspase-8 or -10 are 
cleaved into its active forms. Active initiation caspases promote apoptosis either by cleavage of 
a key execution caspase, caspase-3, or by Bid cleavage and mitochondrial apoptosis stimulation. 
The intrinsic (receptor independent) pathway of apoptosis is regulated mainly by Bcl-2 family 
proteins that control mitochondrial membrane permeability. Antiapoptotic Bcl-2 family proteins 
inhibit mitochondrial membrane pores opening, whereas proapoptotic Bcl-2 family (Bid, Bax, 
Bak) proteins induce the release of cytochrome c and other mitochondrial proteins from the 
intermembrane space into the cytoplasm. Cytochrome c subsequently binds Apaf-1 and 
caspase-9, activated initiation caspase-9 then cleaves caspase- 4. Caspase-3 itself or other 
execution caspases (caspase-6, -7) cleave several proteins necessary for the cell survival causing 
cytosceleton break-up, DNA fragmentation and cell death. 
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1.2 Ubiquitination-deubiquitination process and their role in apoptosis 
Ubiquitination is a posttranslational modification that involves the covalent attachment 
of ubiquitin molecules to targeted proteins that are directed towards the ubiquitin 
proteasome pathway (UPP). UPP is the major system responsible for elimination of 
intracellular proteins especially misfolded cellular proteins in eukaryotes [14, 15]. This 
process regulates a number of cellular processes such as stability, function and 
localization of the targeted proteins. Ubiquitin, a 76 amino acid peptide, covalently 
attaches its C-terminal glycine to the ε-amino group of substrate lysine residues in an 
isopeptide bond and is catalyzed by the sequential action of three enzymes,a 
ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin 
ligase (E3) (Figure 1.2) [15]. E1 activates ubiquitin through the formation of 
ATP-dependent thiol ester bond between the C terminus of ubiquitin and the active 
cysteine site of the E1, which is then transferred to active cysteine site of E3. Finally, E3 
ligase catalyzes the transfer of ubiquitin to a lysine residue on the targeted protein 
(Figure 1.2). These ubiquitin chains can assemble in several different ways depending 
on the lysine site used to form the polyubiquitin chains including lysine K6, K11, K29, 
K48 and K63 [16]. It has been reported that ubiquitin chains can be formed from all 
these lysine residues on the substrate with various lengths and shapes in vitro and in 
vivo [17, 18]. Among them, polyubiquitin chains formed through K48 and K63 appear 
to be more frequent and have been extensively studied [17, 19]. K48-branched 
polyubiquitination is known to regulate protein stability and signals for proteasomal 
degradation of the substrate [15, 17]. Recently, K29 and K33-branched mixed chains 
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have been implicated in the regulation of AMP-activated protein kinase-related kinases 
[20]. Additionally, K29-branched ubiquitin chains promote the proteasomal and 
lysosomal degradation of proteins [21-23], whereas K63-branched polyubiquitination 
plays a key role in the regulation of endocytosis, DNA repair, protein kinase activation 
[24,25], signal transduction [26], intracellular trafficking of membrane proteins [26], 
and stress responses [27]. Taken together, UPP plays a major role in balancing the 
levels of critical proteins involved in major cellular processes such as cell cycle 
progression, DNA replication and repair, transcription, immune responses, and 
apoptosis [28-30]. 
 
 
 
 
 
 
 
[Photograph source: http://www3.ie-freiburg.mpg.de/research-groups/epigenetics/pichler/regulation-of-ubiquitination-by-the-e2-enzyme-e2-25k/] 
Figure 1.2 Ubiquitination and deubiquitination. The process of ubiquitination is regulated by 
organized milieu of E1, E2 and E3 enzymes, which mediate the ligation of ubiquitin to the 
lysine residues in proteins. Ubiquitins can be recycled by the action of DUB enzymes. 
 
Deubiquitination is a process where ubiquitinated proteins can be reversed to 
counterbalance the ubiquitination process by cleaving ubiquitin from 
ubiquitin-conjugated protein substrates with the help of DUBs (Figure 1.2) [27–29]. To 
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date, nearly 100 DUBs have been identified from the human genome and have been 
divided into at least five major families: UBP or USP (ubiquitin-specific processing 
proteases), UCH (ubiquitin carboxy terminal hydrolases), JAMM 
(Jad1/Pad/MPNdomain- containing metallo enzymes), OTU (Otu-domain 
ubiquitin–aldehyde-binding proteins) and Ataxin-3/Josephin [29]. 
The entry of ubiquitin into the apoptosis arena began approximately one decade ago, 
with reports correlating increases in ubiquitin expression during programmed cell death 
in the intersegmental muscle (ISM) of insects and mature lymphocytes. Today, it is clear 
that ubiquitin is critically involved in the regulation of molecules at every phase of 
apoptosis  and has opened an interesting new frontier in the study of apoptosis 
signaling [31-35].  
There is a growing recognition that deubiquitination are also involved in the process of 
switching from prosurvival signaling to cell death signaling. These DUBs either up- or 
down-regulate their protein level or actively regulate their substrates when a cell 
encounters stressors such as DNA damage, unfolded protein, and oxidative stress 
signaling eventually resulting in cell death [36]. Recent studies on the role of DUBs 
have proven productive in revealing its role in the process of apoptosis.  
1.3 TRIM Family Proteins 
The tripartite motif (TRIM) family of proteins is defined by a set of domains known as 
the RBCC motif, which consists of the RING (really interesting new gene 1) finger, one 
or two B-box motifs, and a coiled-coil region (Figure 1.3) [37]. The RING finger is a 
zinc-binding domain with an important role in ubiquitin (Ub) E3 ligase binding to 
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Ub-conjugating enzymes (E2) [38]. B-box is structurally related to the RING domain 
and are required for various biological functions [39], although their roles remain 
unclear. The coiled-coil region is mainly involved in homo- and hetero-dimeric 
interactions for large complex formation [40].  
 
 
 
[Photograph source: http://kumerowgen677s13.weebly.com/motifs-and-domains1.html] 
Figure 1.3 General structure of the TRIM family proteins. TRIMs share a common domain 
organization, with an N-terminal RING domain, followed by a B-box 2 domain, a coiled-coil 
domain, and a C-terminal domain.  (Some TRIMs contain a B-box 1 domain in between the 
RING and B-box 2 domains.)   RING domains are known to function as E3 ligases, and 
facilitate covalent modification of targets with ubiquitin or ubiquitin-like proteins.  TRIM 
C-terminal domains are variable in nature, but generally appear to mediate interactions with 
other protein partners.   
  
Ring domain: The RING domain is defined by a regular arrangement of cysteine and 
histidine residues that coordinate two atoms of zinc [41]. The RING zinc ligation 
system, which is unique to this domain, produces a single integrated structure referred 
to as the ‘cross-brace’ motif. This peculiar structure is the result of zinc coordination 
mediated for the first atom by Cys in position 1,2,5,6 and for the second atom by Cys or 
His in position 3,4,7,8 [42, 43]. There are two main RING subtypes, H2 and C2 [44]. 
The C2 type, which is characterized by a Cys residue in the fifth coordination site, is 
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found in the TRIM/RBCC family. There are few family members that do not present a 
RING domain and are still considered TRIM/RBCC because the rest of the motif 
(B-boxes and coiled-coil) is conserved in order and spacing. With few exceptions, the 
RING domain is typically found within 10–20 amino acids of the TRIM/RBCC protein 
first methionine [45, 46]. Functionally, the RING finger domain has been found to play 
a critical role in mediating the transfer of ubiquitin both to heterologous substrates as 
well as to the RING proteins themselves. This domain is therefore a characteristic 
signature of many E3 ubiquitin ligases.  
B-box domain: The B-box domain is another zinc-binding motif that occurs in two 
flavors, B-box1 and B-box2, which share a similar but distinct pattern of cysteine and 
histidine residues [46, 48]. They mainly diverge in the second potential coordination 
residue, which is a cysteine in B-box1 and a histidine in B-box3. When both B-box 
domains are present, type 1 always precedes type 2; when only one B-box domain is 
present it is always the type 2 [46]. Due to the similarities between these domains, it is 
possible that B-box1 also coordinates one atom of zinc. To date, no specific function has 
been attributed to the B-box domains.  
Coiled-coil domain: A coiled-coil region invariably follows the B-box2 in the entire set 
of TRIM/RBCC proteins [46, 48]. This predicted region is approximately 100 residues 
long, and is frequently broken up into two or three separate coiled-coil motifs. The 
coiledcoil region in the TRIM/RBCC proteins is mainly involved in homo-interactions 
and in promoting the formation of high molecular weight complexes and the definition 
of discrete subcellular compartments within the cell [46].   
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C-terminal domain of TRIM family proteins: While the tripartite motif, and 
especially the B-box domain, is restricted to this protein family, the C-terminal domains 
found in the TRIM/RBCC family members are also present in otherwise unrelated 
proteins. The most-common C-terminal motifs in the TRIM/RBCC proteins are the 
B30.2 domain, the NHL repeats and the associated PHD-BROMO domain. 
Approximately two thirds of the TRIM/RBCC proteins possess a B30.2 domain also 
known as RFP-like domain having been first identified in TRIM27/RFP. This 
170-residue domain of unknown function is also present in a growing number of 
non-TRIM/RBCC proteins. It is composed of three blocks named after the 
more-conserved amino acid stretches, LDP (also known as PRY domain), WEVE and 
LDYE (also known as SPRYdomain) motifs [49]. A less-frequent C-terminal domain 
within the TRIM/RBCC family is the NHL domain. It consists of 2–6 repeats, usually 5 
or 6 in the TRIM/RBCC proteins, of an approximately 40-residue sequence that 
resembles the WD repeat and that assembles to form a multiblade propeller structure 
[50]. No function has been unequivocally attributed to any of the above-mentioned 
C-terminal domains to postulate their role in TRIM/RBCC protein function. 
Functions of TRIM family proteins: Many TRIM proteins are induced by interferons 
(IFNs), which are crucial for resistance to pathogens, and a series of recent studies 
indicates that some TRIM proteins play an important role in the broader immune 
response [51]. For instance, TRIM25 ubiquitinates the caspase recruitment domains 
(CARD) of RIG-I (retinoic acid inducible gene I), a cytosolic receptor for viral RNAs, 
and this ubiquitination is required for IFN production and NF-B promoter activation 
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[52]. TRIM30 negatively regulates Toll-like receptor (TLR)-mediated NF-B 
activation by targeting the adaptors TAB2 [TGF-activated kinase 1 (TAK1)-binding 
protein 2] and TAB3 for degradation, which results in the inhibition of TRAF6 (TNF 
receptor-associated factor 6) activity and IBphosphorylation [53]. TRIM56 induces 
K63-linked polyubiquitination of STING (stimulator of interferon genes), which 
regulates intracellular DNA-mediated, type I IFN-dependent innate immunity [54]. This 
ubiquitination is required for STING dimerization, TBK1 (TANK (TRAF family 
member-associated NF-B activator)-binding kinase 1) recruitment, and IFN promoter 
activation. TRIM23 mediates K27-linked ubiquitination of NEMO (NF-B essential 
modulator), which is important for NF-B activation downstream of RIG-like receptor 
and TLR3 in response to viral dsRNA [55].  
1.4 TRIM27  
TRIM27 (also known as the Ret finger protein, RFP) is one of the TRIM family proteins, 
and was originally found to be fused to the ret proto-oncogene in transformed NIH3T3 
cells [56]. TRIM27 plays a role in transcriptional regulation through interaction with Rb 
and the Mi-2-containing histone deacetylase complex in the nucleus [57, 58]. TRIM27 
contains a nuclear export sequence and shuttles between the cytoplasm and the nucleus 
[59]. In the cytosol, TRIM27 interacts with the IKK family of kinases and with TBK1, 
which inhibits NF-B-dependent and IRF3-dependent transcriptional activation [60]. 
This inhibition does not depend on the RING finger of TRIM27, and the mechanism 
underlying the negative regulation by TRIM27 has not been elucidated. Previous study 
showed that RBCC moiety of TRIM27 triggers a rapid apoptosis through activation of 
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stress activated MAP kinases and caspases which indicate that RBCC moiety might 
participate in the control of cell survival. However, detailed mechanism was not 
elucidated [61]. Recent study suggests that TRIM27 inhibits the muscle differentiation 
by modulating serum response factor and enhancer polycomb1 in the nucleus [62]. 
TRIM 27 has also been shown to negatively regulate the CD4 T cells by ubiquitinating 
the class II PI3K-C2β in the K48 linked manner [63]. In another study TRIM 27 was 
reported to regulate the activation of IgE receptor of mast cells [64]. 
1.5 TNF-αsignaling pathway 
TNF- (tumor necrosis factor-) is a potent inflammatory cytokine that induces 
apoptosis of tumor cells but not normal cells, with the exception of hepatocytes, neural 
cells, and thymocytes [65]. Dysregulation of TNF- signaling is often correlated with 
autoimmune diseases, including type 1 diabetes and Crohn’s disease [66]. Recent 
studies have shown that ubiquitination plays a crucial role in TNF- signaling [67]. 
Upon binding to TNF-, TNFR1 (TNF receptor 1) recruits TRADD (TNFR1-associated 
death domain protein) [68] and triggers the formation of two distinct complexes: 
complex I and II [69] (Figure 1.4). The membrane-associated complex I, which 
activates NF-B, contains TRADD, TRAF2, TRAF5, RIP1 (receptor-interacting protein 
kinase 1), cIAP1 (cellular inhibitor of apoptosis 1) and cIAP3. Both cIAP1 and cIAP2 
are RING finger-containing ubiquitin ligases that catalyze the K-63-linked 
polyubiquitination of RIP1 [70, 71]. K-63 linked polyubiquitin chains recruit TAK1 and 
IKK complexes by binding to the regulatory subunits TAB2 and NEMO, activating 
NF-B to induce a group of cell survival genes [72]. Activation of NF-B via complex I 
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triggers the dissociation of TRADD, RIP1 and TRAF2 from complex I and the 
formation of cytoplasmic complex II, which contains FADD (Fas-associated death 
domain protein) and procaspase-8. Procaspase-8 is processed into the mature caspase-8, 
which cleaves procaspase-3 into the mature effector caspase-3 to initiate apoptosis [69]. 
             
 
 
 
  
 
 
 
 
 
 
 
 
[Photograph source: Reference no. 77] 
Figure 1.4 TNF-α signaling pathway. In response to TNF-α stimulation, RIP1 is recruited to 
TNFR and forms a membrane associated complex I with TRADD, TRAF2/5 and cIAP1/2, 
which in turn leads to polyubiquitination of RIP1 and pro-survival NF-κB activation.  RIP1 
switches function to a regulator of cell death when RIP1 is deubiquitinated by A20 or CYLD. 
Deubiquitination of RIP1 leads to the formation of cytosolic DISC with FADD and caspase-8, 
the so-called complex II. Activation of caspase-8 in DISC leads to apoptosis induction.  
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1.6 Balance between life and death  
The balance between complex I-dependent cell survival and complex II-dependent 
apoptosis is regulated by multiple factors, and TNF- does not induce apoptosis in most 
cells. NF-B activation rapidly induces the expression of several anti-apoptotic proteins 
including cIAPs and c-FLIP (cellular FLICE-inhibitory protein), which prevent the 
activation of procaspase-8. NF-B upregulates the expression of A20, which forms a 
ubiquitin-editing complex that removes K63-linked poly-Ub chains to induce RIP1 
degradation [73, 74]. Another deubiquitinating enzyme, CYLD, which is the product of 
the cylindromatosis tumor suppressor gene CYLD, also specifically cleaves K63-linked 
poly-Ub chains bound to RIP1, releasing RIP1 from complex I and promoting the 
formation of complex II [75-76]. However, additional factors regulating the balance 
between TNF--induced apoptosis and cell survival may exist. 
1.7 Connection of apoptosis, TNF receptor (TNFR) family and autoimmune disease 
There is accumulating evidence that apoptosis, programmed cell death, plays a pivotal 
role in the pathogenesis of autoimmune diseases [78]. A common feature of 
autoimmune diseases is the break down to tolerance of self antigens, a consequence of 
which is the production of auto-antibodies reactive with multiple self proteins. 
Apoptosis acts as a source of immunogens. It has been speculated that highly 
accelerated rates and/or abnormal sites or abnormal processing of apoptotic cells could 
lead to autoantibody production. Defects of apoptotic pathways in T cells promote the 
survival of potentially autoreactive, proinflammatory cells. Failure to eliminate 
activated cells can result in prolonged effector functions, such as CD40 ligand "help" 
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for B cells, inappropriate survival of primed autoantibody-producing B cells, or 
cytokine release by macrophages. Many organ specific autoimmune diseases are 
characterized by immune cell infiltrations that induce the apoptosis [78].  
The mammalian immune system must balance the need for effective immune protection 
against pathogens with the requirement for tolerance to self-antigens to prevent 
autoimmune reactions [79, 80]. Immune tolerance is maintained through deletion of 
self-reactive lymphocytes (by cell death), functional inactivation (anergy), or 
suppression of cell activation via regulatory lymphocytes. Members of the tumor 
necrosis factor (TNF) and TNF receptor (TNFR) family play key roles in the 
development and function of the immune system. Altered regulation of several of these 
factors, such as TNF, TRAIL, CD40L and FasL, may contribute to a breakdown in 
immune tolerance and the development of various autoimmune disease like diabetes, 
experimental autoimmune encephalomyelitis (EAE), inflammatory bowel disease (IBD), 
multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) 
etc. [66, 79, 80].  
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Chapter 2 
2. Research Purpose and Objectives                   
TRIM27 (also known as the Ret finger protein, RFP) is one of the TRIM family proteins 
and due to the presence of RING domain in its structure, TRIM27 has been regarded as 
the ubiquitin E3 ligase enzyme for a long time. Several studies suggest that different E3 
ligase enzymes play a key role in the regulation of various important biological 
signaling pathways including innate immune signaling, TNF-α signaling or apoptosis by 
ubiquitination [51, 67]. TRIM27 has been reported to contain a nuclear export sequence 
and shuttle between nucleus and cytoplasm [59] and shown to regulate the innate 
immune signaling pathway [60], muscle differentiation [62], and the activity of CD4 T 
cells and mast cells [63, 64] through its ubiquitin E3 ligase activity but its role in the 
apoptosis and TNF-  signaling pathway was not elucidated. Although a previous study 
suggests that overexpression of TRIM27 in human embryonic kidney cell could induce 
apoptosis [61], but detailed mechanism is still unknown. Moreover, more than 30 
genome-wide association studies, in several autoimmune diseases, identified hundreds 
of common variants, which suggested a linkage between TRIM27 mutations and various 
autoimmune diseases [82, 83] but there was no experimental evidence in support of this 
hypothesis. In this context, the aim of our study was to unravel the mechanism of 
TRIM27 in apoptosis and TNF-  signaling pathway and find out its connection with 
autoimmune diseases by using murine model system.  
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Chapter 3 
3. Materials and Methods                                             
3.1 Generation of Trim-27
-/-
 mice  
Trim27
-/-
 mice were generated by homologous recombination in TT2 ES cells as 
described previously [84]. The Trim27 gene was disrupted by replacing the 560-bp 
DNA fragment, which corresponds to the 430 bp upstream from the ATG initiation 
codon and the 130 bp of exon 1, with a neomycin cassette (Figure 4.1). This resulted in 
the deletion of the N-terminal initiator codon and the RING finger. Trim27
-/-
 C57BL/6 
congenic mice were generated by backcrossing onto a C57BL/6 genetic background for 
more than ten generations. All mice used were 8-10 week-old males. Experiments were 
conducted in accordance with the guidelines of the Animal Care and Use Committee of 
the RIKEN Institute. 
3.2 TNF-/GalN-induced toxicity  
Mice were sensitized by intraperitoneal administration of GalN [d-(+)-galactosamine 
hydrochloride, Sigma] at 700 mg per kg body weight. After 15 min of GalN treatment, 
recombinant mouse TNF- (20 g/kg, Peprotech) was administered intraperitoneally 
and the mortality rate was measured over the next 24 h.  
3.3 Serum ALT and AST measurement  
Blood was collected from the saphenous vein at 4 h after TNF-/GalN treatment, serum 
was prepared and ALT, AST activities were analyzed by colorimetric method according 
to manufactures protocol (BioVision). 
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3.4 Assay of Caspase 3 and Caspase 8 activity  
Caspase-3/8 activities were measured using caspase3/8 colorimetric activity assay kit 
(Millipore). At 6h after TNF-a/GalN treatment, liver was collected and homogenized in 
a Dounce homogenizer by extraction buffer (Millipore). After brief centrifugation, 
caspase-3/8 activities of the homogenate were measured according to the manufacture’s 
protocol (Millipore).      
3.5 TUNEL assay 
To examine apoptosis in hepatic cells, mouse livers were excised 6 h after treatment and 
fixed in 4% paraformaldehyde. Paraffin-embedded sections (5 m) were analyzed by 
TUNEL assay using an In Situ Cell Death Detection kit (Roche). 
3.6 Histology and immunohistochemistry 
Histopathological analysis of paraffin embedded liver tissue sections were performed by 
H&E staining. Cleaved caspase-3 immunohistochemistry was performed as described 
by Bellenger et al. [85] using anti-cleaved caspase-3 antibody (Cell Signaling 
Technology). 
3.7 Cell culture and cell viability assay 
Mouse embryonic fibroblasts (MEFs) were isolated from embryos at 14.5 days 
postcoitus. Spontaneously immortalized MEFs were isolated. MEFs, the human 
hepatoma cell line HepG2, and the human embryonic kidney cell line 293T were 
cultured in Dulbecco’s modified Eagle’s medium (Nissui Pharmaceuticals) with 10% 
bovine calf serum (HyClone) or fetal calf serum (Roche). To examine cell viability of 
MEF, cells (1x10
4
) were seeded into 96 well plates. At 24 h after incubation, cells were 
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treated with various combination of recombinant mouse TNFα (PeproTech), 
cyclohexamide (Sigma), anti-FAS antibody (BD Bioscience), TRAIL with enhancer 
antibody (Enzo life science), Etoposide (Sigma) or USP7 inhibitor HBX 41,108 
(Calbiochem) for indicated time point as described in the figure legends and cell 
viability was assessed colorimetrically using the cell counting kit-8 (Dojindo, Tokyo). 
3.8 Electrophoretic mobility shift assay (EMSA) 
MEFs (1x10
6
) were cultured for 24 h, and treated with TNF-α (20 ng/ml) for indicated 
time points as described in the figure legend. Nuclear extracts were prepared and 
subjected to EMSA using 
32
P-radiolabelled double-stranded NF-κB probe 
(AGTTGAGGGGACTTTCCCAGGC) as described by Thapa et al. [86]. For super shift 
assay, nuclear extract was pre-incubated with anti-p65 antibody (Santa Cruz) on ice for 
10 min before addition of radiolabelled NF-κB probe.  
3.9 Flow cytometry 
One day after culture, MEF cells were collected with trypsin, washed with PBS and 
FACS buffer (1% BSA/PBS) and blocked using Fc block reagent (BD Bioscience) and 
stained with PE conjugated anti-mouse TNFR antibody (Biolegend) for 30 min at 4°C. 
Cells were washed twice with FACS buffer and analyzed by FACSCalibur   flow 
cytometer (Becton Dickinson). 
3.10 Real-time RT-PCR 
Total RNA was isolated from MEFs using Trizol (Invitrogen). Real-time reverse 
transcription-PCR (RT-PCR) was performed using an ABI 7500 Real-Time PCR 
Instrument and the QuantiTect SYBR Green one step RT-PCR kit (Qiagen), according 
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to the manufacturer's instructions. The PCR conditions were 50°C for 30 min, 95°C for 
15 min, and 40 cycles of 94°C for 15 s, 60°C for 35 s and 72°C for 35 s. The primer 
sequences are shown in Table 3.1. The relative level of mRNA expression was 
normalized against the amount of 18S rRNA using rRNA Control Reagents (Applied 
Biosystems). 
3.11 Subcellular localization of TRIM27 
The subcellular localization of TRIM27 and USP7 was immunohistochemically 
examined as described previously (59). HepG2 cells or MEFs were transfected with 3 or 
1.5 g of the expression vector using Lipofectamine (Invitrogen). Forty-eight hours 
after transfection, cells were fixed and stained with anti-FLAG antibody M2 (Sigma) 
and MitoTracker Red CMXRos (Molecular Probes) or rabbit polyclonal anti-USP7 
antibody (Bethyl Laboratories). The signals were visualized by rhodamine- or 
fluorescein isothiocyanate-conjugated secondary antibodies (Jackson ImmunoResearch), 
and analyzed by confocal microscopy (Zeiss LSM510). For Nycodenz gradient 
fractionation, immortalized MEF cells were transfected with the FLAG-TRIM27 or 
FLAG-RIP1 expression plasmid, harvested in ice-cold homogenizing buffer (10 mM 
Tris-HCl, pH 7.4, 250 mM sucrose, 5 mM EDTA, and protease inhibitor mixture), and 
passed 50 times through a Potter-Teflon homogenizer on ice. A post-nuclear supernatant 
was obtained (3,000 rpm, 10 min, 4°C) and subjected to Nycodenz gradient 
fractionation as described previously [87]. 
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3.12 Comparison of apoptosis-regulating factors by Western blotting 
MEFs were lysed by mild sonication in SDS sample buffer and boiled for 5 min. Protein 
concentration was determined by Lowry method (BioRad Laboratories) and 25-50 μg 
protein was typically subjected to SDS-PAGE. Anti-cleaved caspase-3 (Cell Signaling), 
anti-TNFR1 (R&D Systems), anti-TRADD (Santa Cruz), anti-TRAF2 (Santa Cruz), 
anti-RIP1 (BD Bioscience), anti-FADD (Santa Cruz), anti-CYLD (Santa Cruz), 
anti-USP7 (Bethyl laboratories), anti-TRIM27 (IBL Chemicals), and anti--tubulin 
(Sigma) antibodies were utilized to check the respective endogenous protein levels by 
Western blotting.  
3.13 In vivo ubiquitination assay 
For ubiquitination assay of exogenously expressed proteins, HEK293T or HepG2 cells 
were transfected with a mixture of the indicated plasmids and empty vector using the 
calcium phosphate precipitation method. The plasmids used are pact-FLAG-RIP1, 
pact-FLAG-USP7, pact-3xMyc-Ub to express various forms of Ub, pact-TRIM27 to 
express various forms of TRIM27, including FLAG-tagged or His-tagged TRIM27, 
RING finger mutant, in which Cys-16, Cys-19, Cys-31, and His-33 were replaced with 
Ala, B-box mutant, in which Cys-96, Cys-99, His-107, and Asp-110 were replaced by 
Ala, 4KR mutant in which Lys-79, Lys-304, Lys-380, Lys-382 were replaced with Arg. 
For immunoprecipitation of Flag tagged proteins, at 40 h post-transfection, the cells 
were lysed in 1% SDS-containing RIPA buffer by sonication. Lysates were then 
precleared and diluted with buffer lacking SDS to reduce the SDS concentration to 
0.1%, and immunoprecipitated overnight at 4°C with anti-FLAG M2 monoclonal 
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antibody (Sigma). Immunocomplexes were captured with protein G sepharose beads 
(GE healthcare), washed three times with NETN buffer containing 1 M NaCl and 2% 
NP40, eluted with SDS sample buffer by boiling, and then separated by 7% SDS-PAGE 
and analyzed by immunoblotting. In the case of His-tagged TRIM27, transfected cells 
were scraped into urea buffer (8 M urea, 0.1 M sodium phosphate, pH 8.0, 0.3 M NaCl, 
10 mM N-ethylmaleimide), and sonicated mildly on ice, and His-TRIM27 was purified 
using a HIS-select cobalt affinity gel (Sigma). Western blotting was performed as 
described above. 
In case of endogenous ubiquitination assay, cells were stimulated with mouse TNF- 
(10 ng/mL) and cycloheximide (1 g/mL), and lysed with 1% SDS-containing RIPA 
buffer supplemented with 10 mM N-ethylmaleimide and protease inhibitors by 
vortexing and boiling for 5 min. Lysates were sonicated mildly on ice, diluted and 
precleared with sepharose beads for 1 h at 4°C on a rotating wheel, and 
immunoprecipitated overnight at 4°C with anti-RIP-1 antibody (BD Biosceinces) or 
anti-USP7 antibody (Bethyl laboratories). Immunocomplex was captured, washed, 
eluted and resolved as described above. Following transfer of proteins to nitrocellulose 
membrane, the membrane was autoclaved before incubation at denaturing buffer (6 M 
guanidine-HCl, 20 mM Tris-HCl pH 7.5, 5 mM betamercaptoethanol, 1 mM PMSF) for 
30 min at 4°C. After extensive PBS washing, membrane was blocked at 20% heat 
inactivated bovine calf serum and immunoblotting was performed with anti-Ub 
(Invitrogen) or anti-K63-linked Ub (Millipore) antibody using immunoreaction 
enhancer solution (Toyobo).  
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3.14 Purification and characterization of the TRIM27 complex 
Purification of the complex was performed as described previously [88]. The HeLa S3 
cell clone expressing FLAG/HA–TRIM27 was generated. Cells from a 4 L culture were 
disrupted in hypotonic buffer, and the nuclear pellet was collected by centrifugation at 
25,000 g for 20 min. The pellet was extracted with buffer C (20 mM HEPES, pH 7.9, 
25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM PMSF, and 0.5 
mM DTT) and lysates were collected by centrifugation. The TRIM27 complex was 
purified using anti-FLAG M2 monoclonal antibody (mAb)-conjugated agarose beads 
followed by anti-HA 12CA5 mAb-conjugated agarose beads in wash buffer. The 
purified proteins were separated by 4–20% gradient SDS-PAGE and silver stained. The 
protein bands were excised and analyzed by mass spectrometry. Anti-TRIM27 
(IBL-America) or anti-USP7 (Bethyl Laboratories) antibody was used for 
immunoblotting. 
3.15 Co-immunoprecipitation assays 
For co-immunoprecipitation experiments, 293T cells were directly used or transfected 
using the CaPO4 method with various plasmid mixtures, as described in the figure 
legends.  Cells were collected and lysed by mild sonication in NETN buffer (20 mM 
Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 1mM EDTA, 10% glycerol and protease 
inhibitor cocktail). Lysates were then diluted, pre-cleared and subjected to 
immunoprecipitation by incubation with indicated antibodies for overnight at 4°C. The 
immunocomplexes were captured by protein G sepharose beads, washed three times 
with the lysis buffer containing 0.2% NP-40 and separated by SDS-PAGE. Western 
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blotting was performed using the antibodies described in the figure legends and the ECL 
Western blotting System (Millipore). Aliquots of the lysates were also analyzed by 
Western blotting. For TNF-α induced complex II analysis, MEFs were treated with 
TNF-α (100 ng/ml) and Cyclohexamide (1 μg/ml) for the indicated time period as 
described in the figure legend and FADD/Caspase8/RIP1 complex was isolated and 
analyzed as reported by Ramakrishnan and Baltimore [89]. 
3.16 Knockdown of USP  
The previously reported sequence of shRNA against human USP7 [90] was cloned into 
the pSuper.puro vector and transfected into 293T cells, which were selected with 1 
g/mL of puromycin (Sigma). Cell lysates from the isolated clones were used for 
Western blotting to examine the levels of USP7. For MEFs, the Usp7 gene was knocked 
down using siRNA specific for mouse USP7 (Invitrogen, target sequence: 
5’-GACCCUGGAUUUGUGGUCACAUUAU-3’). For gene-specific knockdown, 
immortalized MEFs were plated in 6 well plates and transfected with 10 M control or 
USP7-specific siRNA using Lipofectamine RNAiMAX (Invitrogen). Forty-eight hours 
after transfection, cell lysates were prepared and USP7 was detected by Western 
blotting.  
3.17 STZ-induced diabetes  
For the STZ-induced diabetes model, male mice aged 8 weeks were injected 
intraperitoneally for five consecutive days with STZ (Sigma) dissolved in citrate buffer 
(pH 4.5) at a concentration of 40 mg/kg. Blood glucose level was measured weekly in 
non-fasted animals from the tail vein using a glucometer (Sanwa Kagaku Kenkyusho 
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Co., Ltd., Japan). Sixty days after the first injection, mice were sacrificed, and the whole 
pancreas was collected, fixed in 4% paraformaldehyde and embedded in paraffin. 
Sections were prepared from three parts of the pancreas and stained with hematoxylin 
and eosin to determine the degree of lymphocyte infiltration. Tissue sections were also 
analyzed by immunohistochemistry with an anti-insulin antibody (C27C9, Cell 
Signaling Technology), anti-cleaved caspase- 3 (cell signaling) and anti-CD3 antibody 
(Abcam) as described previously [85]. For serum insulin measurement, non-fasting 
blood was collected from the saphenous vein of mice before killing. Serum was snap 
frozen in liquid nitrogen and stored at -80°C until determination of insulin concentration 
with a mouse ELISA kit (Mercodia). 
3.18 Primers used in the study 
Primers used for qRT-PCR and for genotyping of mouse are shown in Table 3. 
 
Table 3.1 Sequences of primers used. 
qRT-PCR 
Gene Forward (5′->3′) Reverse (5′->3′) 
A20 GAACAGCGATCAGGCCAGG GGACAGTTGGGTGTCTCACATT 
cFLIP GACTCTAAGCCCCTGCAACC GGAGGGCTTCTCCAAGTGAG 
cIAP2 ACGCAGCAATCGTGCATTTTG CCTATAACGAGGTCACTGACGG 
ICAM CAGATCCTGGAGACGCAGAG GAACCACCTTCGACCCACTG 
Usp7 GCGTGGGACTCAAAGAAGC GAATCATCGCCCTCTGTTGG 
Trim27 CTTCGTGGAGCCTATGATGC CTGCGGACACGACACGTTAG 
Mouse genotype by PCR 
Trim27 CTGCTTCACCAGCTGGGTCA 
CGTTG 
GGAAACTCAGCAGAAGACTAC
GGGCCCACAGACGC 
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Chapter 4 
4. Results                                                                 
4.1 TNF--induced apoptosis is impaired in Trim27-deficient mice 
To understand the physiological role of TRIM27, we generated Trim27-deficient 
(Trim27
-/-
) mice using homologous recombination in ES cells (Figure 4.1). Under 
pathogen-free conditions, Trim27
-/-
 mice exhibited no obvious abnormality. We 
examined the abundance of CD4
+
 and/or CD8
+
 T cells, and also B220
+
 B cells, and 
there was no difference between WT and Trim27
-/-
 mice (data not shown). 
As TRIM27 is a ubiquitin E3 ligase, and ubiquitination plays a role in the regulation of 
TNF-signaling (67), we examined TNF- signaling in Trim27
-/-
 mice. We used a 
D-galactosamine (GalN) sensitized mouse model of liver injury in which 
TNF-induces hepatocyte apoptosis in the presence of GalN [91]. GalN suppresses 
TNF-survival signaling by inhibiting transcription in hepatocytes. WT mice treated 
with TNF-and GalN died within 10 h, whereas 60% of Trim27-/- mice treated under 
the same conditions survived and lived even 24 h after injection (Figure 4.2A). 
TNF-GalN-induced liver injury was observed preferentially in WT mice (Figure 
4.2B). The administration of TNF-GalN induced higher elevation of serum AST and 
ALT levels in WT than in Trim27
-/-
 mice (Figure 4.2C). Histological analysis of liver 
sections indicated that macrophages were infiltrated and hypostasis were evident in 
TNF-GalN-treated WT liver (Figure 4.2D). TUNEL staining of liver sections and 
immunostaining with anti-cleaved caspase 3 showed that the rate of apoptosis was 
higher in WT hepatocytes than in Trim27
-/-
 cells (Figure 4.2E and 4.2F). Furthermore, 
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WT liver homogenates contained higher caspase-3 and caspase-8 activities than 
Trim27
-/-
 liver homogenates (Figure 4.2G). These results indicate that Trim27
-/-
 
hepatocytes are more resistant to the TNF-/GalN-induced apoptosis than WT cells. 
TNF--induced apoptosis was further examined in primary MEFs in the presence of 
cyclohexamide (CHX), which inhibits translation and thus inhibits TNF- survival 
signaling. In WT MEFs, treatment with TNF- or CHX alone did not inhibit cell 
viability, whereas the viability of MEFs treated with both TNF- and CHX was 
significantly reduced (Figure 4.3B). By contrast, TNF-/CHX treatment only slightly 
reduced the cell viability of primary Trim27
-/-
 MEFs. To verify that the lack of TRIM27 
was responsible for this effect, a Trim27
-/-
 MEF cell line expressing exogenous TRIM27 
was generated by infection with the TRIM27-expression retrovirus vector (Figure 4.3A). 
TNF-/CHX reduced the cell viability of the Trim27
-/-
 MEF cell line expressing 
TRIM27, similar to the effect on WT MEFs. When generation of cleaved caspase-3 was 
examined by Western blotting, TNF-/CHX treatment induced higher level of cleaved 
caspase-3 in WT and Trim27
-/-
 MEFs ectopically expressing TRIM27 than in Trim27
-/-
 
MEFs (Figure 4.3C). 
4.2 TRIM27 is not involved in TNF-α-induced survival signaling but required for 
TNF-α-induced apoptosis signaling 
As Trim27
-/-
 mice showed the resistance against apoptosis so next we checked whether 
there is any change in the expression pattern of TNF- receptor in WT and Trim27
-/-
 
mice. There was no difference in the expression level of TNF- receptor between WT 
and Trim27
-/-
 MEFs, as demonstrated by FACS and Western blotting analysis (Figure 
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4.4A B). In addition, other key factors for apoptosis, TRADD, TRAF2, RIP1, caspase-8, 
FADD, CYLD, were also expressed at similar levels in WT and Trim27
-/-
 MEFs 
(Figure 4.4B). 
To determine whether TRIM27 plays a role in TNF- survival signaling, such as 
through NF-B target gene expression, which results in the inhibition of apoptosis, the 
expression of typical survival-related genes including cFLIP, cIAP2, A20, and ICAM 
was assessed in the presence or absence of TNF The results showed that the 
expression levels of these genes were similar between WT and Trim27
-/-
 primary MEFs 
(Figure 4.4C), indicating that TRIM27 does not affect TNF- survival signaling. The 
NF-B activity in WT and Trim27
-/-
 MEFs was examined using EMSA. At various 
times after TNF-/CHX treatment, similar levels of NF-B activities were detected in 
WT and Trim27
-/-
 MEFs (Figure 4.4D). Trim27 mRNA level was also not significantly 
affected by TNF- treatment (Figure 4.5A). 
To investigate the role of TRIM27 in the complex II-dependent apoptosis pathway, the 
complex II formation was compared between WT and Trim27
-/-
 MEFs. In WT cells, 
RIP1 and caspase-8 were co-immunoprecipitated with FADD 90 min after TNF-/CHX 
treatment (Figure 4.6). However, the levels of RIP1 and caspase-8 
co-immunoprecipitated with FADD were lower in Trim27
-/-
 cells than in WT cells. 
These results suggest that TRIM27 is involved in the complex II-dependent apoptosis 
pathway, but not in the complex I-dependent survival signaling pathway. 
To test whether TRIM27 has a general role in the apoptosis induced by various stimuli, 
the Fas-, TRAIL-, or etoposide-induced apoptosis was compared between WT and 
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Trim27
-/-
 MEFs. There was no difference in the Fas-, TRAIL-, or etoposide-induced 
apoptosis between WT and Trim27
-/-
 MEFs (Figure 4.7), suggesting that TRIM27 does 
not have the general role in the various types of apoptosis. 
4.3 Localization of TRIM27 to mitochondria 
Our previous studies suggested that TRIM27 is localized both in the nucleus and in the 
cytosol [59]. As the data described above suggest that TRIM27 is involved in the 
TNF--induced apoptosis in the hepatocytes and MEFs, we examined the subcellular 
localization of TRIM27 in the human hepatocyte-derived cell line HepG2 and in MEFs. 
Immunostaining for TRIM27 in HepG2 cells showed a predominantly cytoplasmic 
pattern, in addition to weak nuclear signals (Figure 4.8). Cytoplasmic TRIM27 signals 
partly overlapped with those of MitoTracker, a mitochondrial-selective fluorescent label, 
indicating the partial localization of TRIM27 to mitochondria. Similar overlapping 
pattern of TRIM27 with MitoTracker was also observed in MEFs (Figure 4.9 top 
panel). Furthermore, TRIM27 subcellular localization was not affected by TNF- or 
TNF-/CHX treatment (Figure 4.9). These results were consistent with a prior study 
that showed that certain signaling molecules involved in TNF- signaling, such as RIP1, 
localize to mitochondria [92].  
To confirm the mitochondrial localization of TRIM27, the cytosolic lysate was 
separated by Nycodenz gradient centrifugation and the resulting fractions were analyzed 
by Western blotting with antibodies against TRIM27, mitochondria-specific HSP70 
(mtHSP70), and PER5. TRIM27 was detected in small amounts in the mitochondrial 
fraction as shown with the anti-mtHSP70 antibody (Figure 4.10A), and in large 
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amounts in the peroxisome. Although the role of TRIM27 in the peroxisome is 
unknown, a recent report showed that the peroxisome is the signaling platform for 
antiviral innate immunity [93]. To further examine the mitochondrial location of 
TRIM27, the mitochondrial fraction was isolated from HepG2 cells transfected with the 
FLAG-TRIM27 expression vector and analyzed by Western blotting (Figure 4.10C,D), 
which showed that a significant amount of TRIM27 was present in mitochondria 
(Figure 4.10D). The isolated mitochondrial fraction was then treated with digitonin to 
disrupt the mitochondrial outer membrane or proteinase K, which degrades proteins on 
the surface of the outer membrane. The pellet fraction after digitonin treatment 
(mitoplast) contained TRIM27, suggesting that TRIM27 is localized in the mitoplast or 
tightly associated with the inner membrane. Furthermore, proteinase K digestion of the 
mitochondrial fraction resulted in the loss of the FLAG-tag containing N-terminal 
portion, suggesting that the N-terminal portion of TRIM27 is located on the outer 
mitochondrial membrane (Figure 4.10E). 
4.4 TRIM27 induces RIP1 deubiquitination  
TRIM25, an RBCC motif-containing protein, directly ubiquitinates RIG-I and promotes 
RIG-I-dependent interferon production in response to ds-RNA (52). We therefore 
hypothesized that the effect of TRIM27 on TNF--induced apoptosis may be mediated 
by ubiquitination of a regulatory factor. Of the several candidates examined, TRIM27 
only affected the ubiquitination status of RIP1. However, contrary to its expected 
function as a Ub E3 ligase, TRIM27 deubiquitinated RIP1 (Figure 4.11A). In the 
co-immunoprecipitation assay, RIP1 was co-precipitated with TRIM27 (Figure 4.11B), 
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suggesting the interaction between TRIM27 and RIP1. Isolation of the cytosolic fraction 
of HepG2 cells using Nycodenz gradient centrifugation indicated that RIP1 also 
localized to mitochondria (Figure 4.10B), as reported previously [92]. We previously 
showed that TRIM27 shuttles between the cytoplasm and the nucleus via its nuclear 
export signal (NES) [59]. The TRM27 NES mutant, which is mainly localized in the 
nucleus, did not induce RIP1 deubiquitination (Figure 4.11C), indicating that 
deubiquitination of RIP1 is mediated by cytosolic TRIM27. 
A polyubiquitin (poly-Ub) chain is generated through the formation of a link between 
one of the seven Lys side chains of Ub and the C-terminal Gly of another Ub. To 
determine the type of poly-Ub chain on RIP1 that is removed by TRIM27, we used Ub 
mutants in which all but one Lys residue are replaced by Arg. Expression of Ub mutants 
with active K27, K29, or K48 linkages resulted in the TRIM27-induced 
deubiquitination of RIP1, whereas K11- and K63-linked poly-Ub was removed only 
slightly by TRIM27 (Figure 4.11D). These results suggest that TRIM27 removes K11-, 
K27-, K29-, K48-, or K63-linked poly-Ub from RIP1. However, the poly-Ub chains 
bound to RIP1 may have a complex structure with various Lys linkages; therefore, the 
specificity of TRIM27 for a particular chain remains unclear.  
4.5 USP7 is required for the TRIM27-induced deubiquitination of RIP1 
To understand the mechanism underlying the deubiquitination of RIP1 by TRIM27, 
TRIM27-interacting proteins were identified by purifying the complex formed. HeLa 
cells were infected with a retrovirus encoding FLAG- and HA-tagged TRIM27 
(FH-TRIM27), and a cell line expressing FH-TRIM27 was isolated. The 
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FH-TRIM27-containing complex was purified using anti-FLAG and anti-HA antibodies, 
and analyzed by SDS-PAGE. This complex contained a 120-kD band in addition to 
FH-TRIM27 (Figure 4.12A), which was identified by mass spectrometry as USP7 (also 
known as HAUSP, herpesvirus-associated ubiquitin-specific protease), a 
ubiquitin-specific protease. USP7 colocalized with TRIM27 in the cytoplasm and in the 
nucleus (Figure 4.12B), suggesting that these proteins interact. Furthermore, USP7 
co-immunoprecipitated with TRIM27 in HepG2 cells transfected with the TRIM27 
expression vector (Figure 4.12C). 
To examine whether USP7 is needed for the TRIM27-induced deubiquitination of RIP1, 
we generated USP7-knockdown 293T cell lines by introducing an siRNA expression 
vector. Among multiple cell lines isolated, one clone (#44) expressed USP7 at a 
significantly low level (Figure 4.13A). When RIP1 was co-expressed with increasing 
amounts of TRIM27 in this cell line, RIP1 deubiquitination was not observed (Figure 
4.13B), indicating that USP7 is required for the TRIM27-induced deubiquitination of 
RIP1. These results suggest that the TRIM27-USP7 complex binds to RIP1, resulting in 
its deubiquitination.  
To further examine this interaction, we performed co-immunoprecipitation assays. 
Using 293T cell lysates, endogenous RIP1 and USP7 were co-immunoprecipitaed with 
endogenous TRIM27 (Figure 4.14A). However, in 293T cells ectopically expressing 
the three proteins, TRIM27 was coimmunoprecipitated with USP7, but not with RIP1 
(Figure 4.14B). When the USP7 mutant (C223A), in which the catalytic domain of the 
protease was disrupted by point mutation [94], was used, TRIM27 was 
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coimmunoprecipitated with both USP7 and RIP1 (Figure 4.14C). These results 
indicated that these three proteins interact, but RIP1 is immediately released after its 
deubiquitination by USP7. There was no difference in the Usp7 mRNA level between 
WT and Trim27
-/-
 MEFs (Figure 4.5B), indicating that TRIM27 regulates 
TNF--induced apoptosis not via regulating the USP7 level. 
4.6 Ubiquitination of USP7 by TRIM27 is required for the TRIM27-induced 
deubiquitination of RIP1  
To examine the role of TRIM27 in the TRIM27/USP7 complex-induced 
deubiquitination of RIP1, we investigated whether TRIM27 ubiquitinates USP7. 
Ubiquitination assays in 293T cells showed that the WT and the RING finger TRIM27 
mutant, in which four Zn-binding residues of RING finger were replaced by Ala, 
ubiquitinated USP7, while the B-box mutant, in which four Zn-binding residues of 
B-box were replaced by Ala, did not (Figure 4.15A,B). Similar results were obtained 
using the USP7 catalytic domain mutant (C223A) (Figure 4.15C). As both the RING 
finger and the B-box mutants interacted with USP7 (Figure 4.15D), these results 
suggest that the B-box of TRIM27 acts as the catalytic domain for the ubiquitination of 
USP7, or that the B-box of TRIM27 recruits another Ub E3 ligase. To analyze the 
nature of the TRIM27-generated poly-Ub linkage on USP7, various Ub mutants in 
which all but one Lys residue were mutated to Arg were used for ubiquitination assays. 
TRIM27 catalyzed the Lys-linked polyubiquitination of USP7 in all cases (Figure 
4.15E), suggesting that TRIM27 mediates the addition of poly-Ub chains to USP7 
without selectivity for a particular linkage type. 
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As Lys-869 of USP7 is ubiquitinated [95], we examined the possible ubiquitination of 
USP7 at Lys-869. TRIM27 did not ubiquitinate the USP7-K869R mutant in which 
Lys-869 was mutated to Arg (USP7-K869R) (Figure 4.16A). Expression back of 
siRNA-resistant WT USP7 mRNA in USP7-knockdown 293T cells recovered the 
TRIM27-induced RIP1 deubiquitination (Figure 4.16B Left and 4.13B), whereas 
overexpression of siRNA-resistant USP7-K869R mRNA did not (Figure 4.16B, right). 
These results indicate that the ubiquitination of USP7 by TRIM27 is required for the 
TRIM27-induced deubiquitination of RIP1. 
When TRIM27 was expressed with USP7, the TRIM27 level was increased (Figure 
4.15B). To further confirm, we examined the effect of increasing amounts of USP7 on 
the TRIM27 level and its ubiquitination. TRIM27 level was increased by USP7 in a 
dose-dependent manner, and the degree of TRIM27 ubiquitination per TRIM27 
molecule decreased (Figure 4.17). These results suggest that USP7 stabilizes TRIM27 
by removal of poly-Ub from TRIM27. 
As TRIM27 is a ubiquitin E3 ligase, we have examined whether TRIM27 is 
autoubiquitinated via its RING finger domain. Ubiquitination degree of TRIM27 RING 
finger mutant was much lower than that of WT (Figure 4.18A). Next we determined the 
ubiquitinated sites of TRIM27 by mass spectrophotometry. Mutation of four 
ubiquitination sites (4KR) in TRIM27 dramatically decreased its ubiquitination (Figure 
4.18B). Two TRIM27 mutants, RING finger and 4KR mutants, were localized 
exclusively and mainly in the nuclei, respectively (Figure 4.18C). Thus, 
autoubiquitination of TRIM27 may be required for its localization in the cytoplasm. 
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Furthermore, Ring finger mutant of TRIM27 was colocalized with USP7 in the nucleus, 
while 4KR mutant was not (Figure 4.18C). This may be due to the decreased 
interaction between 4KR mutant and USP7 (Figure 4.18D). 
4.7 Deubiquitination of RIP1 by the TRIM27-USP7 complex is required for 
TNF--induced apoptosis.  
To further confirm that USP7 plays a role in TNF--induced apoptosis, Usp7 mRNA 
was down-regulated in immortalized MEF by using mouse siRNA. Western blot 
analysis showed that cells treated with siRNA sequence #407 expressed significantly 
lower levels of USP7 than control cells (Figure 4.19A). Down-regulation of USP7 
made the cells resistant to TNF-/CHX-induced apoptosis compared to control cells 
(Figure 4.19B). Furthermore, when WT MEFs were treated with the USP7 inhibitor 
HBX [96], cells were also resistant to TNF-/CHX-induced apoptosis (Figure 4.19C). 
When generation of cleaved caspase-3 was examined by Western blotting, TNF-/CHX 
treatment induced higher level of cleaved caspase-3 in control cells compared with 
Usp7 knockdown or HBX treated MEFs (Figure 4.19D). 
We next examined the ubiquitination of endogenous RIP1 in response to TNF-/CHX 
treatment using WT, Trim27
-/-
, and Usp7 knockdown MEF cell lines. The level of 
ubiquitinated RIP1 in Trim27
-/-
 cells and USP7 knockdown cells was higher than in WT 
and control cells (Figure 4.20A, B). The difference in the degree of RIP1 ubiquitination 
between WT and Trim27
-/-
 MEFs and between WT and Usp7 knockdown MEFs was 
more evident at 30 and 120 min after TNF-/CHX treatment than at 0 min after 
treatment. This is consistent with the results that TRIM27 is involved in the 
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TNF--induced apoptosis, but not in the TNF--induced NF-B activation, which 
occurs at early timing after TNF- stimulation. We also examined the K63-linked 
ubiquitination of RIP1. The level of K63-linked ubiquitination of RIP1 in Trim27
-/-
 
cells and USP7 knockdown cells was higher than in WT and control cells (Figure 
4.20A,B). However, The difference in the degree of K63-linked RIP1 ubiquitination 
between WT and Trim27
-/-
 MEFs and between WT and Usp7 knockdown MEFs was 
much less compared with the difference in the total ubiquitination of RIP1. As there was 
no significant difference in the NF-B activity between WT and Trim27
-/-
 MEFs 
(Figure 4.4D), the K63-linked ubiquitinated RIP1 detected in Trim27
-/-
 MEFs may 
contain the complex structure of poly-Ub together with K63-linked Ub, so that it may 
not function to activate the survival signaling. These results further support that the 
TRIM27/USP7 complex plays a role in TNF--induced apoptosis by mediating RIP1 
deubiquitination.  
4.8. Trim27
-/-
 mice are prone to STZ-induced diabetes 
Defect in apoptosis are associated with autoimmune diseases [78,108]. As Trim27
-/-
 
mice showed the resistance against apoptosis and previous genome-wide association 
studies in several autoimmune diseases and hundreds of common variants suggested an 
association between TRIM27 polymorphisms and certain autoimmune diseases, such as 
type 1 diabetes [82], therefore, we examined the susceptibility of Trim27
-/-
 mice to 
streptozotocin (STZ)-induced diabetes, an animal model of type 1 diabetes, which is 
thought to arise after an autoimmune attack on pancreatic islets involving T-cells and 
macrophages [97]. Assessment of blood glucose levels in Trim27
-/-
 and WT mice 
 36 
 
during 60 days after the first STZ injection showed that Trim27
-/-
 mice had significantly 
higher blood glucose levels than WT mice at 14, 35, 42, 56, and 60 days (Figure 4.21A). 
Furthermore, Trim27
-/-
 mice showed a significantly higher incidence of diabetes than 
WT mice (Figure 4.21B). These results correlated with the significant hypoinsulinemia 
detected in Trim27
-/-
 mice at day 60 after the first STZ injection, which was greater than 
the reduction in insulin levels in WT mice (Figure 4.21C).  
In addition, Trim27
-/-
 mice showed a significant reduction of the insulin-positive areas 
per islet (Figure 4.22A). The reduced amount of insulin positive area in Trim27
-/-
 mice 
might be due to increased apoptosis of pancreatic β cells as assessed by immunostaining 
of cleaved caspase 3 (Figure 4.22B). To investigate whether the increased sensitivity of 
Trim27
-/-
 mice to the diabetogenic effects of STZ was associated with exaggerated 
insulitis, pancreatic sections were histologically examined. The number of islets without 
infiltration was significantly lower in Trim27
-/-
 mice than in WT mice, whereas the 
number of islets with clear infiltration was increased (Figure 4.23A). The clearly 
displayed infiltrated area of Trim27
-/-
 mice were also strongly stained with ant-CD3 
antibody, a general marker for lymphocyte (Figure 4.23B). These results indicated that 
Trim27
-/-
 mice were susceptible to autoimmune diabetes.  
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Figure 4.1 Generation of Trim27-deficient (Trim27
-/-
) mice. (A) Schematic representation of 
the mouse Trim27 gene, the targeting vector, and the predicted disrupted allele. The probes used 
for Southern blot analyses are shown together with the predicted sizes of the hybridizing 
fragments. Restriction enzymes: B, BamHI; E, EcoRI; H, HindIII; N, NcoI; P, PstI; X, XhoI. 
Black and shaded boxes indicate the exon 1 region encoding the 5’-untranslated region and the 
N-terminal region of Trim27, which covers the RING finger, B box, and a part of the coiled-coil 
domain. In the targeting vector, the region encoding the N-terminal portion of Trim27, which 
includes the RING finger domain, was replaced by the PGK-neo cassette indicated by the gray 
box. (B) Southern blot analysis of genomic DNA extracted from the tails of wild-type (WT), 
Trim27
+/-
, and Trim27
-/-
 mice. (Left panel) Genomic DNA digested with NcoI was hybridized 
with the 5' probe to yield 6.6-kb and 8.8-kb bands, representing the WT and targeted alleles, 
respectively. Note that one NcoI site surrounded by parenthesis in the targeting vector was 
disrupted. (Right panel) Genomic DNA digested with HindIII was hybridized with the 3' probe 
to yield 8.0-kb and 1.5-kb bands, representing the WT and targeted alleles, respectively. (C) 
Immunodetection of Trim27. Whole cell lysates from xx of WT, Trim27
+/-
, and Trim27
-/-
 mice 
were used for immunoblotting with anti-Trim27 antibody. Equal amounts of total protein were 
loaded in each lane.  
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Figure 4.2 TNF-α induced apoptosis is impaired in Trim27 deficient mice (A) Resistance of 
wild-type (WT) and Trim27
-/-
 mice to TNF- cytotoxicity. WT (n = 6) and Trim27-/- (n = 10) 
mice were treated with TNF- (20 g/kg) and GalN (700 mg/kg) and their mortality was 
monitored over next 24 h. (B) The liver of mouse 6 h after TNF-/GalN injection. (C) Serum 
AST and ALT levels were determined 4 h after TNF-/GalN injection. Data are averages ± 
SEM (n = 3 for WT, 4 for Trim27
-/-
 mice ). *, p < 0.05. (D-F) Histological analysis (H&E 
staining) (D), TUNEL staining (E), and anti-cleaved caspase-3 immunostaining (F) were 
performed on liver sections 6 h after TNF/GalN injection. Infiltrated macrophages (yellow 
arrows) and hypostasis are observed in WT section. Scale bar, 10 m. (G) Activities of 
caspase-3 and caspase-8 in liver homogenate of WT and Trim27
-/-
 prepared at 6 h after 
TNF/GalN injection. Data are averages ± SEM (n = 3). *, p < 0.05.  
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Fig 4.3 Trim27
-/- 
MEFs are resistant to TNFα induced apoptosis. (A) Expression of TRIM27 
in immortalized MEFs. Immortalized MEFs from WT and Trim27
-/-
 mice analyzed by Western 
blotting against TRIM27. The Trim27
-/-
 immortalized MEF cell line expressing exogenous 
TRIM27 was established by infection with a TRIM27-expression retrovirus vector, and was also 
used. Equal amounts of total protein were loaded in each lane. (B) WT and Trim27
-/-
 MEFs (1 x 
10
4
 cells) were plated on 96-well plates and treated with TNF- (10 ng/mL), or CHX alone (1 
g/mL), or in combination with TNF- (10 ng/mL) and CHX (1 g/mL). Six hours after 
treatment, cell viability was measured. Average value (n = 5) relative to the non-treated cells is 
shown with SD. **, p < 0.01. The Trim27
-/-
 MEF cell line expressing exogenous TRIM27 was 
used as the control.  (C) Cleaved caspase-3 was determined by immunoblot analysis of MEFs 
lysates prepared at 3 h after TNF-/CHX addition. 
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Figure 4.4 TRIM27 is not involved in TNF--induced survival signaling. (A) TNFR1 
expression. TNFR1 expression in WT and Trim27
-/-
 MEFs was examined by flow cytometry. 
(B) Expression of TNF-α signaling components. Expression levels of indicated proteins were 
compared between WT and Trim27
-/-
 MEFs by Western blotting. -Tubulin was used as a 
control. (C) Analysis of the expression of survival-related genes. Primary MEFS from WT and 
Trim27
-/-
 mice were treated with TNF- (20 ng/ml), and the expression levels of four 
NF-B-dependent survival-related genes were analyzed by qRT-PCR. Mean values + S.D. (n = 
3) is shown. (D) EMSA of NF-B after treatment of MEFs with TNF-. TNF- (20 ng/ml) was 
added to the culture of WT and Trim27
-/-
 MEFs, and nuclear extracts were prepared at the 
indicated time. EMSA was performed using the NF-B DNA probe. Where indicated, anti-p65 
antibodies were added, so that supershift of NF-B-DNA band was observed.  
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Figure 4.5 Effect of TNF- treatment on Trim27 and Usp7 expression. Primary MEFS from 
WT or Trim27
-/-
 mice were treated with TNF- (20 ng/ml), and expression levels of Trim27 (A) 
or Usp7 (B) were analyzed by qRT-PCR. Mean values + S.D. (n = 3) is shown. 
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Fig 4.6 TRIM27 is involved in the TNF-induced complex II formation. TRIM27Analysis 
of complex II. Lysates of WT and Trim27
-/-
 MEFs were prepared at the indicated time after 
TNF- (100 ng/mL)/CHX (1 g/mL) addition, and immunoprecipitated with anti-FADD, 
followed by Western blotting to detect RIP1, caspase-8, and FADD. 
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Figure 4.7 FAS-, TRAIL-, or etoposide-induced apoptosis. WT and Trim27
-/- 
MEFs were 
treated with Ant-Fas antibody (5 μg/ml) and CHX (1 μg/ml) (A), Recombinant human TRAIL  
(100 ng/ml in conjugation with 2 μg/ml enhancer antibody) (B) or etoposide ( 200 μM) (C). 24 
h (TRAIL/FAS) or 36 hr (Etoposide) after treatment cell viability was measured. Average of 
values relative to the non-treated cells is shown with SD.  
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Figure 4.8 Subcellular localization of TRIM27. HepG2 cells were transfected with a 
FLAG-TRIM27 expression vector, incubated with Mitotracker, fixed with 1% 
paraformaldehyde, and incubated with an anti-FLAG antibody. After treatment with the 
corresponding secondary antibodies, fluorescence signals were visualized with a laser confocal 
microscope. The far right panel shows the merged signals for Mitotracker (red) and TRIM27 
(green) 
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Figure 4.9 Localization of TRIM27 is not affected by TNFα in MEF. Immortalized MEFs 
were transfected with FLAG-TRIM27 expression vector, and treated with TNF- (20 ng/ml) for 
indicated time. Cells were incubated with Mitotracker, fixed with 1% paraformaldehyde, and 
incubated with anti-FLAG antibody. After the treatment of the secondary antibodies, 
fluorescence signals in cells were visualized under the laser confocal microscope. The signals 
for Mitotracker (red) and TRIM27 (green) were merged on the right most panel.  
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Fig 4.10 Biochemical proof for mitochondrial localization of TRIM27. (A) Subcellular 
fractionation experiments. Cytosolic fractions of immortalized WT MEFs transfected with 
FLAG-TRIM27 expression plasmids were subjected to Nycodenz gradient fractionation. The 
levels of FLAG-TRIM27, the mitochondrial marker mtHSP70, and the peroxisome marker 
PER5 in each fraction were analyzed by immunoblotting. (B) Localization of RIP1 in 
mitochondria. Cytosolic fractions of immortalized WT MEFs transfected with FLAG-RIP1 
expression plasmids were subjected to Nycodenz gradient fractionation as described above. The 
levels of FLAG-RIP1 and mtHSP70 in each fraction were analyzed by immunoblotting. (C) 
Mitochondria were purified from HepG2 cells transfected with the FLAG-TRIM27 expression 
vector, and treated with digitonin or proteinase K. Fractions such as the mitoplast were 
separated by centrifugation. (D) Equivalent amounts of each fraction were analyzed by 
SDS-PAGE, followed by Western blotting with anti-FLAG antibody. (E) The localization of 
TRIM27 in mitochondria, which was suggested by the data, is schematically shown below. 
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Figure 4.11 TRIM27 deubiquitinates RIP1. (A) Deubiquitination of RIP1 by TRIM27. 
HEK293T cells were transfected with the FLAG-RIP1 expression vector or control empty 
vector, together with the Myc-Ub expression vector and increasing amounts of the TRIM27 
expression vector. Upper panel: cell lysates were immunoprecipitated with an anti-FLAG 
antibody and immunocomplexes were analyzed by Western blotting against anti-Myc. Lower 
panel: cell lysates were probed against an anti-FLAG antibody. (B) Co-immunoprecipitation of 
TRIM27 with RIP1. Upper panel: HEK293T cells were transfected with vectors expressing 
FLAG-RIP1 and T7-TRIM27, and cell lysates were immunoprecipitated with anti-T7 antibody 
or control IgG, followed by Western blotting with anti-FLAG. Asterisk indicates a non-specific 
band. Lower panel: lysates were analyzed by Western blotting with anti-TRIM27. (C) RIP1 
deubiquitination is impaired with the TRIM27 NES mutant. Experiments were performed as 
described in (a) by substituting the NES mutant of TRIM27, which cannot be exported from the 
nucleus, for WT TRIM27. (D) Analysis of the ubiquitin chains removed from RIP1. 
Experiments were performed as described in (a), except for the use of different vectors 
expressing the indicated ubiquitin mutants instead of WT ubiquitin 
 48 
 
 
 
 
 
 
Figure 4.12 TRIM27 forms a complex with USP7 (A) Formation of a complex between 
TRIM27 and USP7. The TRIM27 complex was purified from HeLa cells expressing FLAG- and 
HA-tagged TRIM27 (FH-TRIM27) or control HeLa cells (mock) using anti-FLAG and anti-HA 
antibodies, and analyzed by SDS-PAGE followed by silver staining. Mass spectrometry analysis 
identified the two bands indicated by arrows as USP7 and FH-TRIM27. (B) Co-localization of 
TRIM27 and USP7. HepG2 cells were transfected with vectors expressing T7-tagged TRIM27 
and FLAG-USP7, and immunostained with anti-T7 and anti-FLAG antibodies. After treatment 
with the corresponding secondary antibodies, fluorescence signals were visualized under a laser 
confocal microscope. Merged signals for T7-TRIM27 and FLAG-USP7 are shown on the far 
right panel. (C) Co-immunoprecipitation of TRIM27 and USP7. HEK 293T cells were 
transfected with the FLAG-TRIM27 expression vector or control empty vector, and cell lysates 
were immunoprecipitated with anti-FLAG antibody or control IgG. The immunocomplexes 
were subjected to Western blotting using anti-FLAG or anti-USP7 antibodies.  
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Fig 4.13 USP7 is required for the TRIM27-induced deubiquitination of RIP1. Generation of 
USP7 knockdown 293T cells. The 293T cell transfectants expressing the small hairpin RNA 
against the USP7 gene were isolated, and cell lysates were analyzed by Western blotting against 
anti-USP7. Equal amounts of total protein were loaded in each lane. (E) Knockdown of USP7 
abrogates the TRIM27-induced deubiquitination of RIP1. Experiments were performed as 
described in Figure 3a, except for the use of USP7-knockdown cells (#44) instead of parental 
293T cells.  
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Figure 4.14 TRIM27, RIP1 and USP7 forms a complex. (A) Coimmunoprecipitation of 
endogenous TRIM27 with RIP1 and USP7.  Whole cell lysates from HEK 293T cells were 
immunoprecipitated with anti-TRIM27 or control IgG, and the immunocomplexes were 
analyzed by SDS-PAGE, followed by Western blotting with anti-RIP1, anti-USP7, or 
anti-TRIM27. (B and C) The RFP-USP7 complex transiently interacts with RIP1. HEK 293T 
cells were co-transfected with the T7-RFP and FLAG-RIP1 expression vectors and the WT (B) 
or catalytic domain mutant (C223A) (C) of FLAG-USP7. Upper panel: lysates were 
immunoprecipitated with anti-T7 or control IgG and analyzed by Western blotting against 
anti-FLAG. Lower panel: lysates were subjected to Western blotting against anti-T7. Asterisk 
indicates a non-specific band. 
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Fig 4.15 TRIM27 ubiquitinate the USP7. (A) Domain structure of TRIM27. (B) TRIM27 
ubiquitinates USP7 via its B-box domain. HEK293T cells were co-transfected with 
FLAG-USP7 and Myc-ubiquitin expression vectors and a plasmid for the expression of the 
indicated form of TRIM27. Upper panel: cell lysates were immunoprecipitated with anti-FLAG 
followed by immunoblotting against anti-Myc. Lower panel: lysates were analyzed by Western 
blotting with anti-FLAG or anti-TRIM27 antibodies. (C) Ubiquitination of USP7 by TRIM27 
was examined as described in (B), except that the USP7 mutant, in which Cys-223 in the 
catalytic domain was mutated to Ala, was used instead of WT USP7.(D) 
Co-immunoprecipitation of USP7 and various forms of TRIM27. HEK293T cells were 
transfected with a vector expressing the indicated form of FLAG-TRIM27, and cell lysates were 
immunoprecipitated with anti-FLAG antibody or control IgG. The immunocomplexes were 
subjected to Western blotting using anti-FLAG or anti-USP7 antibodies (E) Analysis of 
polyubiquitin chains attached to USP7. Ubiquitination of the USP7 catalytic mutant C223A, 
which lacks ubiquitin protease activity, was examined as described in (c), except for the use of 
the USP7-C223A mutant instead of WT USP7 and the indicated mutant ubiquitin instead of WT 
ubiquitin. 
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Figure 4.16 TRIM27 induces RIP1 deubiquitination by ubiquitinating and activating 
USP7. (A) USP7 Lys-869 is ubiquitinated by TRIM27. HEK293T cells were transfected with 
an expression vector for FLAG-linked WT or the USP7 K869R mutant, in which Lys-869 is 
mutated to Arg, together with Myc-ubiquitin and TRIM27 expression vectors. Upper panel: cell 
lysates were immunoprecipitated with anti-FLAG antibody, followed by immunoblotting 
against anti-Myc. Lower panel: lysates were analyzed by Western blotting with anti-FLAG 
antibody. (B) TRIM27 ubiquitination of USP7 at Lys-869 is required for TRIM27-induced RIP1 
deubiquitination. The USP7-knockdown HEK293T cells were transfected with the FLAG-RIP1 
expression vector, together with vectors expressing Myc-ubiquitin and WT or the K869R USP7 
mutant, which was resistant to USP7 shRNA, and increasing amounts of the TRIM27 
expression vector. Upper panel: Cell lysates were immunoprecipitated with anti-FLAG antibody, 
and the immunocomplexes were subjected to Western blotting with anti-Myc antibody. Lower 
panel: Lysates were analyzed by Western blotting with anti-FLAG or anti-USP7 antibodies.  
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Fig 4.17 Effect of USP7 on TRIM27 ubiquitination. HEK293T cells were transfected with the 
FLAG-TRIM27 expression vector or control empty vector, together with the Myc-Ub 
expression vector and increasing amounts of the USP7 expression vector. (Left) Upper panel: 
Cell lysates were immunoprecipitated with anti-FLAG antibody, and the immunocomplexes 
were subjected to Western blotting with anti-Myc antibody. Lower panel: Lysates were 
analyzed by Western blotting with anti-FLAG antibody. (Right) The amount of sample per lane 
was adjusted to contain similar level of FLAG-TRIM27, and analyzed as described above. 
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Fig 4.18 Autoubiquitination of TRIM27. (A) HEK293T cells were transfected with the vector 
to express WT or RING finger mutant (RF), or control empty vector, together with the Myc-Ub 
expression vector. Upper panel: cell lysates were immunoprecipitated with anti-FLAG antibody, 
and the immunocomplexes were subjected to Western blotting with anti-Myc antibody. Lower 
panel: lysates were analyzed by Western blotting with anti-TRIM27 antibody. (B) HepG2 cells 
were transfected with the vector to express His-tagged WT or 4KR mutant of TRIM27, in which 
four ubiquitination sites, Lys-79, Lys-304, Lys-380, and Lys-382, were replaced by Arg, or 
control empty vector, together with the Myc-Ub expression vector. Upper panel: His-tagged 
TRIM27 was purified using cobalt-resin, and was subjected to Western blotting with anti-Myc 
antibody. lower panel: Lysates were analyzed by Western blotting with anti-TRIM27 antibody. 
(C) Co-localization of TRIM27 mutants and USP7. HepG2 cells were transfected with vectors 
expressing T7-tagged TRIM27 mutants and FLAG-USP7, and immunostained with anti-T7 and 
anti-FLAG antibodies. After treatment with the corresponding secondary antibodies, 
fluorescence signals were visualized under a laser confocal microscope. (D) 
Co-immunoprecipitation of TRIM27 mutants with USP7. HEK293T cells were transfected with 
the vector to express FLAG-tagged TRIM27 mutants. In the Ala mutant, putative 
phosphorylation sites (Ser-476, 478, and 482) of TBK-1 and IKK were replaced by Ala. Whole 
cell lysates from transfected cells were immunoprecipitated with anti-FLAG, and the 
immunocomplexes were analyzed by Western blotting with anti-USP7 or anti-FLAG. 
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Figure 4.19 USP7 is required for TNF-α induced apoptosis (A) Knockdown of Usp7 using 
siRNA in immortalized MEF. Three different sequences of mouse Usp7 siRNA were 
transfected, and cell lysates were analyzed by Western blotting with anti-USP7 (upper) or 
anti-tubulin (lower) antibodies. (B and C) USP7 is involved in TNF-α/CHX-induced apoptosis. 
Cell viability was examined as described in Figure 1I using control immortalized MEFs, 
Usp7-knockdown cells (B), and WT cells pretreated with the USP7 inhibitor HBX 41,108 (20 
μM) for 4 h (C). Experiments were repeated three times, and average value relative to the 
non-treated cells is shown with SD. **, p < 0.01. (D) Cleaved caspase-3 was determined by 
immunoblot analysis of MEFs lysates prepared at 3.5 h after TNF-α/CHX addition. 
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Figure 4.20 TRIM27-USP7 regulation of RIP1 ubiquitination in the presence of TNF and 
CHX. (A and B) Ubiquitination of endogenous RIP1 after TNF/CHX treatment. Immortalized 
WT, Trim27
-/-
 (A) or Usp7-knockdown (B) MEFs were treated with TNF- (10 ng/ml) and 
CHX (1µg/ml) for the indicated time. Endogenous RIP1 was immunoprecipitated and analyzed 
by immunoblotting with anti-Ub (upper panel) or anti-K63-linked Ub (lower panel) antibody. 
Lysates were also analyzed by Western blotting with anti-RIP1 or anti-USP7 antibodies.  
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Figure 4.21 Trim27
-/-
 mice are prone to STZ-induced diabetes. (A) Blood glucose levels of 
WT and Trim27
-/-
 mice after streptozotocin (STZ) injection. Mice were injected 
intraperitoneally with STZ, and blood glucose level was measured weekly. Mean value + S.E.M. 
(WT, n = 6; Trim27
-/-
, n = 7) is shown. (B) Incidence of STZ-induced diabetes. WT (n = 6) 
and Trim27
-/-
 (n = 7) mice were injected with multiple low doses of STZ, and the blood glucose 
level was monitored weekly in non-fasted animals using a glucometer. Animals were considered 
diabetic when the blood glucose level exceeded 300 mg/dL. (C) Serum insulin levels of control 
(no treatment) and STZ-treated mice at 60 days after the first STZ injection. Each bar represents 
the mean + SEM. *, p < 0.05; N.S., no significant difference. 
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Figure 4.22 Reduced β-cell mass and increased apoptosis in STZ induced diabetic Trim27-/- 
mice. (A) Decreased β-cell mass in Trim27-/- mice at 60 days after the first STZ injection. 
Pancreatic sections were immunostained with anti-insulin antibody, and the size of 
insulin-positive islets and its frequency were measured. Islet size was averaged from six WT 
and seven Trim27
-/-
 mice, using three sections from each animal. The average frequency + SEM 
are shown as a bar graph (left), and typical sections are shown (right). **, p < 0.01; N.S., no 
significant difference. Sacle bar 10μm. (B) Representative immunohistochemistry for cleaved 
caspase-3 of pancreatic islets of WT and Trim27
-/-
 mice (n=3).  
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Figure 4.23 STZ induced diabetic Trim27
-/-
 mice showed severe infiltration of lymphocytes 
in pancreatic islet (A) Histological examination of pancreatic islets. Mice were treated as 
described in Figure 4.21, and pancreatic sections were stained with hematoxylin and eosin. An 
average of 75 sections (5 μm thickness) from each WT (n =6) and Trim27-/- (n = 7) mouse were 
examined. The degree of infiltration was classified into three types and their frequency was 
calculated. The average frequency + SEM are shown as a bar graph (upper), and typical sections 
are shown (below). Scale bar, 10 μM (B) Anti-CD3 immunohistochemistry of pancreatic section 
of STZ treated mice.  
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Chapter 5 
5. Discussion                                                              
The results of the present study indicate that Trim27-deficient mice are resistant to 
TNF-/GalN-induced apoptosis, and TRIM27 forms a complex with and 
polyubiquitinates USP7, which deubiquitinates RIP1 (Figure 5.1). There may be 
multiple forms of ubiquitinated RIP1 which contain a complex structure of Ub in 
addition to K63-linked Ub. The deubiquitination of various forms of ubiquitinated RIP1 
may trigger the formation of complex II, leading to the induction of apoptosis. In the 
signaling events downstream of complex I, K63-linked polyubiquitination of RIP1 is 
essential for the activation of NF-B and thus the induction of cell survival-related 
genes because this polyubiquitin chain binds to TAB2 and NEMO, activating TAK1 
and IKK complexes (Figure 5.1) [67, 70-72]. The TRIM27/USP7 complex removed 
K27-, K29-, and K48-linked poly-Ub chains from RIP1, but had a little effect on K-11- 
and K-63-linked poly-Ub. Consistent with this, TRIM27 knockdown did not affect the 
expression of survival-related genes. The addition of K11-linked poly-Ub to RIP1, 
which binds to NEMO, has been reported [98], but its role in the induction of survival 
genes is unknown. Although K48-linked ubiquitination is known to target proteins for 
proteasomal degradation, knockdown of TRIM27 did not increase RIP1 protein levels. 
These results suggest that RIP1 is modified by complex poly-Ub chains containing 
K11-, K27-, K29-, K48-, and K63-linked Ub. The Ub structure specificity of TRIM27 
differs from that of CYLD and A20, which remove K63-linked poly-Ub chains from 
RIP1 and suppress the expression of survival-related genes [73-77]. In the absence of 
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TNF-α treatment, the degree of ubiquitination of RIP1 in Trim27
-/-
 cells was higher 
than that in WT cells, and this difference became more dramatic at 30 min and 120 min 
after TNF-/CHX treatment (Figure 4.20). These results suggest that 
TRIM27-dependent deubiquitination of RIP1 occurs constitutively in the absence of 
TNF-α, and its role in the generation of non-ubiquitinated RIP1 becomes more evident 
in cells exposed to TNF- α, in which the expression of survival genes, including the 
RIP1 deubiquitinating enzymes A20 and CYLD is suppressed.   
TRIM27 ubiquitination of USP7 at Lys-869 is required for USP7-induced 
deubiquitination of RIP1. The B-box mutant of TRIM27 was able to bind to USP7 but 
failed to ubiquitinate USP7, whereas the RING finger mutant of TRIM27 ubiquitinated 
USP7. TRIM family proteins have two types of B-boxes, 1 and 2, and TRIM27 has only 
B-box 3. The two types of B-box have a similar structure to that of the RING finger 
[39]. Our results suggest that the B-box functions as a Ub E3 ligase or that the B-box 
recruits another Ub E3 ligase. The ability of TRIM27 to add K6-, K11-, K27-, K29-, 
K33-, K48-, and K63-linked poly-Ub to USP7 suggests that the structure of the poly-Ub 
chains attached to USP7 is complex. USP7 regulates the level of p53 and Mdm2 by 
inhibiting their degradation via removal of the K48-linked poly-Ub from these proteins 
[99]. Non-ubiquitinated USP7 actively removes poly-Ub from p53 and Mdm2, 
indicating that the polyubiquitination of USP7 is not required for its protease activity. 
Furthermore, non-ubiquitinated USP7 forms a complex with TRIM27, indicating that 
the polyubiquitination of USP7 is not required for TRIM27/USP7 complex formation. 
Therefore, the Ub chain on USP7 may function to recruit RIP1 to the TRIM27/USP7 
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complex. The catalytic site mutant of USP7, but not WT USP7, forms a complex with 
RIP1 (Figure 4.14), suggesting that RIP1 is released immediately after deubiquitination 
by USP7. Therefore, the attachment of poly-Ub to USP7 may stabilize the transient 
RIP1/USP7/TRIM27 complex. 
TRIM27 and RIP1 were partly localized to mitochondria and peroxisomes. USP7 was 
also shown to localize to mitochondria [100]. However, as the TRIM27/USP7 complex 
may have multiple functions, these data do not necessarily indicate that RIP1 
deubiquitination occurs in mitochondria. Recently, the peroxisome was shown to 
function as the signaling platform for antiviral innate immunity [93]; therefore, the 
TRIM27/USP7 complex could play a role in innate immunity. In fact, TRIM27 was 
suggested to inhibit the release of human immunodeficiency virus 1 (HIV) and murine 
leukemia virus (MLV), and to inhibit MLV gene expression [101]. TRIM27 and USP7 
were also partly colocalized in the nucleus, suggesting their possible involvement in 
transcriptional regulation. 
It was shown that USP7 binds to TRAF2 and TRAF6 and suppresses the 
TNF--induced NF-B activation [102]. However, TRIM27 did not affect the 
TNF--dependent NF-B target gene expression (Fig. 4.4C), and TRIM27 did not 
affect the TRAF6 ubiquitination (data not shown). Furthermore, it is unlikely that all the 
USP7 proteins form the complex with TRIM27. Therefore, TRIM27 may not interact 
with TRAF2/6 together with USP7. Overexpression of TRIM27 suppresses IL-1-, virus 
infection- and TNF--induced cytokine production, and TRIM27 has been shown to 
bind to IKK/IKK and suppress their activities [60]. However, in the present study, 
 63 
 
TRIM27 knockout did not affect the expression of survival-related genes. 
Overexpression of certain TRIM proteins may result in a specific phenotype that is not 
induced by loss-of-function. In particular, because the TRIM family of proteins can 
form hetero-multimers via the coiled-coil region, the overexpression of certain TRIM 
proteins may affect the function of other members of the family. TRIM21 ubiquitinates 
TRIM5 and targets it for degradation [103], suggesting that the overexpression of 
TRIM27 could affect the level of other TRIM protein(s). TRIM27 has also been shown 
to activate JNK (Jun N-terminal kinase) and induce apoptosis [104], suggesting another 
possible function that needs to be investigated through loss-of-function assays. 
To understand the biological significance of defective apoptosis in Trim27
-/-
 mice we 
used the multiple low dose STZ injected mice as a murine model for autoimmune 
diabetes. STZ is a glucose analog that enters the beta cells through glucose transporter 2 
(Glut2) and causes diabetes in mice and rats by selectively destroying pancreatic β cells 
by DNA alkylation which ultimately initiate the immune reactions against islets mainly 
by infiltrating T cells and macrophages, which closely resembles human Type I diabetes 
[105,106]. Moreover, the onset of disease in STZ induced diabetic model is controlled 
and the animals involved do not have immune abnormalities that complicate studies in 
models of spontaneous autoimmune diabetes. 
Consistent with the well-known concept that defects in apoptosis are frequently 
associated with autoimmune diseases [107], Trim27
-/-
 mice were susceptible to 
STZ-induced diabetes in our study (Figure 4.21). Our findings were also consistent 
with the results of recent genome-wide association studies linking autoimmune diseases 
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and genetic polymorphisms, which showed an association between human TRIM27 
genes and type 1 diabetes [82]. Although in this study we could not show any direct 
evidence in support of the mechanism of crosstalk between defective apoptosis and 
autoimmune Type I diabetes but as the Trim27
-/-
 mice showed increased infiltration of 
lymphocyte in the pancreas in response to STZ (Figure 4.23), we speculate that 
peripheral lymphocyte homeostasis and self tolerance mechanism to minimize the 
accumulation of autoreactive lymphocytes might be defective in Trim27
-/-
 mice due to 
abrogated TNF-α induced apoptosis. Lymphocyte apoptosis has been reported as a 
principal system for immune tolerance which is maintained through deletion of 
self-reactive lymphocytes (by cell death), functional inactivation (anergy), or 
suppression of cell activation via regulatory lymphocytes [108]. Members of the tumor 
necrosis factor (TNF) and TNF receptor (TNFR) family play key roles in the 
development and function of the immune system. Therefore altered regulation of several 
of these factors, such as TNF, TRAIL, CD40L and FasL, may contribute to a breakdown 
in immune tolerance and the development of autoimmune disease [108]. 
Defect in the TNFR family receptors or their downstream signalling pathways have 
been linked to uncontrolled lymphocyte proliferation in peripheral lymphoid organs, 
and the development of autoimmune diseases in mice and humans [109-111]. Previously, 
it has been reported that mutant mice lacking TRAIL (TNF-related apoptosis-inducing 
ligand) are prone to STZ-induced diabetes [98]. This susceptibility is caused by a defect 
in the negative selection of thymocytes and the generation of autoreactive T-cells. In 
addition, TRAF6 deficiency also induces autoimmunity by affecting the development of 
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thymic stroma cells [112]. Deficiency in mature lymphocyte apoptosis has been also 
reported to correlate with the development of disease: Studies in lpr and gld mice, 
defective in TNFR family protein CD95 and CD95L respectively, confirmed this 
hypothesis [113]. Moreover, genetic deficiencies of IL-2 or its receptor, crucial 
elements for T cell susceptibility to antigen-induced apoptosis, lead to lymphoid 
hyperplasia and autoimmunity. Moreover, it has been demonstrated that patients 
with autoimmune lymphoprolipherative syndromes present mutation in death receptor 
machinery concerning abnormalities of TNFR family protein CD95/CD95L [111,112]. 
As TRIM27 is widely expressed in many types of cells, including thymocytes, thymic 
stroma cells, T-cells, and macrophages, further analysis will be required to elucidate the 
mechanism by which the loss of TRIM27 affects the development of autoimmune 
diseases. 
Mutation of most of the genes does not result in a disease phenotype, whereas a 
TRIM27 mutation in one allele could cause disease by expressing a dominant-negative 
form. TRIM family proteins form multimer complexes through coiled-coil domain 
interactions. Therefore, the presence of mutant proteins might block the function of WT 
proteins via formation of a multimer complex, as reported for the p53 tumor suppressor 
[114]. Further studies with emphasis on the analysis of diabetes patients are necessary 
to understand the role of TRIM27 in human type 1 diabetes. 
A recent study that used Trim27-deficient mice, which were independently generated 
from ours, showed that TRIM27 catalyzes the K48-linked ubiquitination of the class II 
phosphatidylinositol 3 kinase C2 (PI3KC2), promoting inhibition of its enzymatic 
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activity, and negatively regulates CD4 T-cells by inhibiting TCR-stimulated Ca
2+
 influx 
and cytokine production [63]. TRIM27 also negatively regulates IgE receptor activation 
and downstream signaling by the same mechanism [64]. Further analyses using 
Trim27
-/-
 mice may help to elucidate the uncharacterized physiological roles of 
TRIM27. 
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Figure 5.1 Model describing the role of TRIM27-USP7 in TNF-induced apoptosis. Upon 
binding to TNF-, TNFR1 binds to TRADD and triggers the formation of complex I and II. 
Complex I, containing TRADD, TRAF2, TRAF5, RIP1, cIAP1 and cIAP2, activates NF-B. 
The ubiquitin ligases cIAP1 and cIAP2 catalyze the K-63-linked polyubiquitination of RIP1, 
which binds to TAB2 and NEMO. This induces activation of TAK1 and IKK complexes, 
followed by NF-B activation to induce the transcription of survival genes. Activation of 
NF-B triggers the dissociation of RIP1 from complex I and the formation of complex II 
containing FADD and procaspase-8, which induces apoptosis. Multiple forms of ubiquitinated 
RIP1, which contains not only K63-linked Ub but also other various forms of Ub, may exist. 
TRIM27 forms a complex with and ubiquitinates USP7, which deubiquitinates RIP1, 
upregulating complex II-dependent apoptosis. 
 
 
 
 
 
 68 
 
Chapter 6 
6. Conclusion                                                          
Tumor necrosis factor  (TNF-) plays a role in apoptosis and proliferation in multiple 
types of cells, and defects in TNF--induced apoptosis are associated with various 
autoimmune diseases. Here, we show that TRIM27, a tripartite motif (TRIM) protein 
containing RING finger, B-box, and coiled-coil domains, positively regulates 
TNF--induced apoptosis. Trim27-deficient mice are resistant to 
TNF-/D-galactosamine-induced hepatocyte apoptosis. Trim27-deficient mouse 
embryonic fibroblasts (MEFs) are also resistant to TNF-/cycloheximide-induced 
apoptosis. TRIM27 forms a complex with and ubiquitinates the ubiquitin-specific 
protease USP7, which deubiquitinates receptor-interacting protein 1 (RIP1), resulting in 
the positive regulation of TNF--induced apoptosis. Trim27-deficient mice were 
susceptible to streptozotocin (STZ)-induced diabetes, a typical autoimmune disease. 
Our findings indicate that the ubiquitination-deubiquitination cascade mediated by the 
TRIM27-USP7 complex plays an important role in TNF--induced apoptosis. 
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